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Abstract 
Nutrition support administered as Parenteral Nutrition (PN) is given to patients that have a 
non-functioning gut. Parenteral nutrition is the administration of nutrients and fluids into the 
venous system and is potentially associated with life-threatening complications. It is therefore 
essential that the care and management of PN is co-ordinated by clinicians that have the 
specialist knowledge and expertise to ensure it is given safely and appropriately. 
This is a Phase one regional pilot study which aims to examine the current standard of PN care 
in hospitals in New Zealand using a clinical audit process. A secondary aim is to identify if any 
remediable factors are found in the care of patients receiving PN which can then be used to 
improve patient care, focussing on the following themes:  
           • Indication for PN 
           • Type of PN 
           • Prescribing PN 
           • Catheter choice, insertion and care 
           • PN associated complications 
           • Nutrition teams 
Six local hospitals from four large district health boards covering a population of 1.64 million 
were enrolled. Included were adult, paediatric (<16yrs), and neonates (<1yr) patients receiving 
PN in hospital during the period of Jan 1st to June 31st 2011. Patients receiving PN in the home 
were excluded, even if they were admitted into hospital within the study period.   
iv 
 
620 cases of PN use (288 adult, 68 paediatric, 264 neonates) were identified within the study 
period. 151 cases (70 adult, 17 paediatric, 64 neonates) were purposely selected for expert 
peer review. There were, 66 adults (94%), 7 paediatric (41%), 49 neonates (76%) 
questionnaires returned, of these, de-Identified clinical records were also available for 100% of 
the adult and 41% of the neonate cases for expert review. 
Data for 66 adults (34 male: 32 female) were returned and peer reviewed by advisor assessors 
however only 65 completed advisor assessor questionnaires were returned. 
The results of the adult cases examined showed that only 12.7% of cases were deemed to 
involve Good Practice- defined as the standard for which advisors would consider being 
acceptable and in accordance to the recommended guidelines. Sixty five per cent of cases 
demonstrated that there was room for improvement in the care provided. Nineteen per cent 
of cases examined were considered to be of a less than satisfactory standard.  
A limitation of this study included lack of sufficient paediatric/neonate experts available for 
peer review. 
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1. Introduction 
Parenteral nutrition (PN) is the administration of nutrients, fluid, minerals and electrolytes 
directly into the veins and is used in patients whose ability to absorb nutrients may be 
inadequate, unsafe or in whom the intestine may be inaccessible.  Parenteral nutrition can be 
used long term (over a period of months to years) in patients that may have long term or 
irreversible intestinal failure; however, it is more commonly used short term (for a period of 
days to weeks) as nutritional support for a temporarily non-functioning intestine.   
This thesis presents a regional pilot study (phase one) of a clinical audit examining current 
management of PN in the Auckland and Northland regions. The main aim of this study was to 
examine current practice in PN care, a secondary aim was to identify remediable factors which 
could lead to improved patient outcomes. PN care was audited using the European Society of 
Parenteral and Enteral Nutrition (ESPEN) clinical practice guidelines (CPG), and the National 
Institute for Health and Clinical Excellence (NICE) guideline; Nutrition support in adults. Several 
themes of PN care were examined in this audit; indication for PN, type of PN given, catheter 
choice, insertion and care, PN associated complications and finally, availability and role of 
nutrition support teams (NST). An overall grade of the PN care provided was then given by 
advisor assessors.  Phase one of the study also determined the appropriateness of the data 
collection tools for the New Zealand setting. Learning from this a national audit (Phase two) is 
planned for a later date and will not form part of this thesis.  
Chapter one provides a background of the rationale for this study and the study aims. 
Additional information on the consequences of malnutrition are described, together with 
information on what PN is, the role of PN as nutrition support, the context in which it should 
be administered and the significant potential complications associated with  its administration. 
The researcher’s interest in the study will be summarised followed by an overview of the 
remaining chapters of this thesis. 
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Background  
Normal Function of the Gastrointestinal Tract and Consequences of Malnutrition 
The primary function of the gastrointestinal (GI) tract is to provide the body with a supply of 
nutrients, electrolytes and fluid. The GI tract’s function involves ingestion, digestion and 
absorption of food and fluid into the blood, and elimination of residue and waste products. 
The tract extends from the lips to the anus and includes the mouth, pharynx, oesophagus, 
stomach and the intestines. Each part of the GI tract has a unique function which is regulated 
by autonomic processes, endocrine secretions and local intrinsic controls.  
Disruption of the GI tract, through excision, trauma, or malfunctioning of the tract can lead to 
malnutrition.  Specific malnutrition issues often arise as a result of the disruption of specific 
parts of the GI tract. For example, the loss of a portion of small bowel affects the ability to 
absorb nutrients, while issues affecting the pharynx can have an effect on swallowing, thus 
reducing the ability to take in adequate food and water. 
Barendregt, Soeters, & Allison discuss the consequences of malnutrition which can be 
considerable, affecting several biological systems (2004). 
? Mental function - Anxiety and depression is seen to increase in malnutrition and 
decreases with re-feeding. In addition specific vitamin deficiencies and changes in 
calcium, magnesium and phosphate levels can result in impaired brain function. 
? Muscle function – This declines after a few days of fasting, then worsens further as cell 
mass is lost.  
? Cardiovascular and renal function – Loss of cardiac muscle decreases cardiac output, 
resulting in bradycardia and hypotension, and the resultant decrease in heart volume 
has been found to be proportional to the loss of body weight. Furthermore, mineral 
and electrolyte disorders can cause cardiac arrhythmias and specific vitamin 
deficiencies may cause cardiac failure. Severely malnourished patients may also 
develop peripheral circulatory failure. The ability to excrete excess salt and water is 
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also diminished as a consequence of malnutrition resulting in higher levels of 
extracellular fluid volumes, as evidenced by clinical oedema. 
? Respiratory function – Protein depletion in the body of more than 20% affects 
respiratory muscle structure and function. It is associated with a decrease in 
diaphragmatic muscle mass and respiratory muscle strength, resulting in an inability to 
cough effectively and impaired resistance to microbes. 
? Gastrointestinal function – In malnutrition there is impaired absorption of lipids, 
disaccharides, and glucose. There is also a decrease in the essential GI secretions 
which contribute to further malabsorption. In addition, changes in bacterial flora or 
intestinal infection may also increase malabsorption and diarrhoea.  Gastrointestinal 
changes connected to malnutrition also impair intestinal barrier function, which is 
understood to exacerbate multiple organ failure. 
? Thermoregulation – Severe weight loss impairs the thermogenic response to cold. A 
drop in core temperature of only 1-2⁰C can cause impaired cognitive function, un-
coordination, confusion and muscle weakness. With severe malnutrition the febrile 
response is lost and fever may be absent even when significant life threatening 
infection is present.  
? Immune system – Malnutrition impairs cell mediated immunity and therefore lack of 
resistance to infection. 
? Wound healing – Malnutrition delays healing, particularly the early stages of wound 
healing.  
Options for Feeding the Malnourished Patient 
There are several options for nutritional support to prevent or treat malnutrition. Oral or 
enteral methods of nutrition support are the preferred option over the parenteral route for a 
variety of reasons.  These include maintenance of gut integrity and functioning (Sigalet, 
Mackenzie, & Hameed, 2004), reduction in potential risks associated with PN (Gramlich et al., 
2004), and the far more favourable costs involved in this type of re-feeding (Michael, Hannah, 
& Joshua, 2011). Patients with difficulty swallowing or reduced levels of consciousness may 
require an enteral feeding tube in order to supplement their nutritional requirements. 
Choosing the best option for nutrition support is dependent on several factors:  the anatomy 
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of the GI tract, the clinical indication for nutrition support, the expected duration of feeding 
and the accessibility and functioning of the GI tract.  
Orogastric or nasogastric tubes are the most common tubes used for enteral feeding (Best, 
2005). They are generally used for short term nutrition support (4-6 weeks). This method of 
feeding allows a nutritional supplement to be administered directly into the stomach, which 
then acts as a reservoir, releasing nutrition into the rest of the gut at a steady rate as it would 
normally. Complications of this type of nutrition support are the discomfort caused to patients 
during the insertion of the feeding tube and the high risks associated with aspiration. The 
correct positioning technique is important to reduce this risk. Patients with severe illnesses 
may experience delayed gastric emptying which often means this type of feeding is poorly 
tolerated in this group.  
Naso-jejunal feeding tubes are inserted into the nose and pass through both the 
oesphagogastric and pyloric sphincter into the jejunum. This positioning is believed to reduce 
the risk of aspiration (Bankhead et al., 2009). Because this technique bypasses the stomach 
reservoir, patients are sometimes not able to tolerate large bolus volumes of feed. This type of 
feeding is often used in patients known to have delayed gastric emptying or those that have 
had upper gastrointestinal surgery where feeding is distal to any vulnerable anastomosis. 
Gastrostomy and Jejunostomy tubes are passed directly through the skin either into the 
stomach (Gastrostomy), or the jejunum (Jejunostomy). Placement can be done endoscopically, 
radiologically or surgically. These types of tubes are generally utilised when longer term 
feeding is required. Associated risks are similar to orogastric and naso gastric tubes and are 
dependent on expert technique and correct placement (Smith, 2012).  
Finally, if there is no access to the gut, or there is a non-functioning gut, PN can be used to 
supply nutrition directly into the bloodstream via a venous access device. However, PN is often 
associated with significant potential complications (Hartl, Jauch, Parhofer, & Rittler, 2009; 
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Montalvo-Jave, Zarraga, & Sarr, 2007; Ukleja & Romano, 2007). Therefore it should be used 
judiciously, and be managed by clinicians with the specific knowledge required in order to 
prevent any of the potentially fatal complications occurring (Nightingale, 2010; Wilson & 
Blackett, 2012).  
Venous Access Options for Parenteral Nutrition 
In order to administer PN, reliable venous access is required. Venous access is the placement 
of a catheter into a vein to administer fluids or medications directly into the bloodstream. 
Catheters can be short or long depending on the intended function of their use. Peripheral 
catheters are generally about 3 inches long and sit in small veins, these are typically used for 
administering fluids and non-irritant medications, mid-lines are usually approximately 8 inches 
long, sitting in slightly larger veins than peripheral catheters, therefore enabling the 
administration of slightly more potentially irritant fluids.  Central venous access refers to 
placing a venous catheter that leads directly to the major veins connected to the heart or into 
the heart itself. These catheters can vary considerably in length, and those used for adults, 
from approximately 38cm to 120cm. They are usually used for longer term therapy, or when 
multiple different fluids are being administered or when the fluids being given are known to be 
extremely irritant to veins due to the osmolality of the solutions.  
 
There are various administration options available for the delivery of PN, peripheral venous 
catheters, midlines or central venous catheters. ESPEN clinical guidelines, ‘Central Venous 
Devices’, recommend that PN be administered into the most clinically appropriate site via a 
central venous catheter (Pittiruti, Hamilton, Biffi, MacFie, & Pertkiewicz, 2009), the tip of 
which should be sited at the distal superior vena cava or upper third of the right atrium. 
Caution must be taken however, as there is evidence that placement into the right atrium can 
cause cardiac injury and arrhythmias (Austin & Stroud, 2007). To safely administer PN, reliable 
venous access is required.  Initial assessment for which is the most appropriate venous access 
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device should include an assessment of vascular accessibility, vascular access history, co-
morbidities, associated medication access requirements and the expected duration of therapy. 
There has been a significant increase in the use of peripherally inserted central catheters 
(PICC) for administering short term (over a period of weeks to months) PN, which are thought 
to reduce the risks of complication (Gosbell, 2005). For longer term administration of PN 
(months-years), portacaths or tunnelled lines should be considered. Parenteral nutrition can 
also be administered peripherally via short cannula’s or midlines for short periods (days) using 
a low osmolality formula (<850mOsm/L), however great care must be taken to ensure the 
correct formula is used to prevent complications such as phlebitis.   
There are some routes of venous access that are not considered suitable for the administration 
of PN. Femoral catheters are not considered appropriate for PN use due to their higher 
associated risks of contamination at the exit site in the groin and potential for thrombosis. 
Likewise internal jugular placement is not recommended as the exit site is difficult to nurse, 
increasing risk of contamination and catheter related infection.  
Complications of PN  
There are well documented complications associated with PN and include: 
1. Central Venous Catheter (CVC) complications - these can be relatively common and 
include mechanical complications, catheter related sepsis and central vein thrombosis. 
Complications such as pneumothorax, arterial puncture, bleeding and malposition can occur 
during placement. However these are more commonly associated with subclavian or internal 
jugular CVC placement, especially when ultra-sound guidance is not used (Crozier & McKee, 
2005). Risks of pneumothorax are greater with subclavian CVC insertion compared with 
internal jugular CVC placement - A chest x-ray is therefore considered essential after upper 
body CVC placement to exclude pneumothorax and to confirm correct positioning 
(Amerasekera, Jones, Patel, & Cleasby, 2009).  
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Air emboli can also occur with both centrally inserted catheters as well as peripherally inserted 
catheters (PICC). These can be caused when the catheter is accidentally left open and the high 
blood flow in central vessels pulls significant amounts of air into the circulation. In addition, 
thrombosis can occur if the CVC is not inserted far enough into the superior vena cava or 
upper third of the right atrium, especially when using PN with >900mOsm/L. (Austin & Stroud, 
2007).  
Correct placement of the central venous access device (CVC) must be confirmed prior to use 
especially when using a higher osmolality formula (>900mOsm/L). A post insertion x-ray should 
be considered mandatory if the position has not been checked during insertion, however there 
is evidence that ultra-sounded guided venepuncture is associated with lower risk of 
complication (Gann Jr & Sardi, 2003; Palepu, Deven, Subrahmanyam, & Mohan, 2009).  
Migration of the catheter tip can occur, more commonly during insertion however this can be 
rectified if identified during time of insertion (Geng, Bin, Li, & Yan, 2011). Migration can also 
occur during the dwell time of the CVC, often due to factors such as accidental tugging or 
during dressing changes. Finally, mechanical complications such as thrombosis and 
misplacement can be avoided by using standardized insertion and maintenance protocols 
(Pittiruti, et al., 2009). These protocols should include appropriate choice of CVC, technician 
experience, correct positioning of CVC and good maintenance procedures of flushing and 
observations.  
2. Infections – A common complication because PN is an ideal growth medium for micro-
organisms. Catheter related bacteraemia is one of the commonest complications of PN with its 
prevention and management being one of the key roles of nutrition support team (Wesley, 
1995). Infection is usually attributable to either poor aseptic technique contaminating the 
lumen during accessing or at the point of insertion when skin infections can be introduced into 
the blood stream (Safdar & Maki, 2006). 
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Sepsis is often associated with indicators such as pyrexia, elevation of white blood cells and 
increase of inflammatory markers, for example, C - reactive protein (CRP) (Bickley, 2009). As 
the source of Infection is not always catheter related, determining the source of sepsis is 
absolutely essential to determine appropriate management. Other necessary investigations 
include the collection of samples such as urine, wound swabs, drainage and sputum 
specimens, and x-rays and/or computed tomography (CT) scans to exclude respiratory or 
abdominal causes. Blood cultures taken from the CVC along with a simultaneous blood sample 
taken peripherally can confirm or rule out catheter related sepsis and is generally accepted as 
standard practice. 
Confirmation of CVC infection is unequivocal if a sample taken from the catheter lumen 
produces a colony count greater than 1000 times than that taken from a simultaneous 
peripheral blood sample. A positive CVC sample with a negative peripheral sample may 
suggest catheter related sepsis but may equally be caused by contamination. A negative 
catheter sample with a positive peripheral sample suggests a non- catheter related source of 
infection. It is recommended that central venous catheters used for short term PN that have 
been confirmed as infected are generally removed and replaced, together with antibiotic 
therapy. (O'Grady et al., 2011; Pittiruti, et al., 2009) Catheters inserted for long term PN use, 
such as tunnelled catheters or portacaths may be treated using an antibiotic lock technique in 
an attempt to save the catheter however in severe cases of sepsis, catheter removal may be 
required. 
Catheter-related sepsis can be prevented by using cost effective evidence based practices that 
include education and training of staff who are accessing catheters (Dumont & Nesselrodt, 
2012; O'Grady, et al., 2011; Pittiruti, et al., 2009; Scales, 2011). In particular adequate hand 
washing, correct choice of device and site of insertion, use of maximal barrier precautions 
during insertion, use of chlohexidine as antiseptic during insertion and to disinfect when 
accessing, appropriate choice of dressing, routine change of giving sets and timely removal on 
completion of PN. 
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3. Re-feeding syndrome (RFS) –is a potentially fatal, but entirely avoidable condition that 
can occur in malnourished patients who undergo rapid re-feeding, by oral, enteral or 
parenteral routes (Byrnes & Stangenes, 2011). It is a highly complex syndrome with 
hypophosphatemia as the main clinical feature as well as changes in glucose, protein and fat 
metabolism, sodium and fluid balance abnormalities, thiamine deficiency, hypokalaemia and 
hypomagnesaemia. Other metabolic complications include abnormal glucose metabolism, 
deficiencies of fatty acids and trace metals, hepatobiliary and gastrointestinal dysfunction and 
electrolyte abnormalities. 
The main cause of RFS is rapid re-feeding following a period of starvation (Mehanna, Moledina, 
& Travis, 2008). As a result of the metabolic changes in early starvation, the body switches 
from using carbohydrate as the main energy source to using protein and fat. As fasting 
continues, the body aims to conserve muscle and protein by decreasing use of ketone bodies 
and tissues switch to using fatty acids for their energy source. An increase in blood levels of 
ketone bodies ensues, thereby stimulating the brain to convert to using ketone bodies as its 
main energy source; subsequently the liver decreases its rate of gluconeogenesis, thereby 
conserving muscle protein. As a result of these metabolic changes, several intracellular 
minerals such as phosphate, magnesium and potassium become severely depleted, even 
though the concentrations of these minerals may remain normal or near normal in serum 
(Mehanna et al.). 
When feeding is restarted, the body metabolism suddenly changes from catabolism (a set of 
metabolic pathways that break down molecules into smaller units and release energy) to 
anabolism (the set of metabolic pathways that construct molecules from smaller units; these 
reactions require the energy produced during catabolism). The re-introduction of 
carbohydrates stimulates insulin release, leading to the uptake of glucose, potassium, 
magnesium phosphorus, and water into cells. Protein and fat synthesis are stimulated, further 
consuming minerals. In addition, more cells are produced, also using up the supply of minerals. 
The net result of these changes is a deficit in intra and extracellular mineral concentrations, 
leading to the clinical complications of re-feeding syndrome. 
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The most important step in preventing re-feeding syndrome is the early identification of high 
risk patients (Ahmed, Travis, & Mehanna, 2011; Barendregt, et al., 2004). These include 
patients with minimal food intake for a period of more than 5 days, those who have been 
chronically under-nourished and those who have diminished physiological reserve.  Patients 
may have become malnourished due to reduced intake (e.g. dysphagia, anorexia nervosa, 
depression, and alcoholism) or reduced absorption of nutrition (e.g. inflammatory bowel 
disease and coeliac disease), or due to increased metabolic demands (e.g. in cancer and 
surgery). 
In 2006 the National Institute for Health and Clinical Excellence (NICE) in the UK identified 
major and minor risk factors to help identify patients at risk of RFS and provided guidelines to 
prevent or reduce the risk of electrolyte disturbances (NICE, 2006). These factors include BMI, 
weight loss history, current nutritional status, and serum levels of specific substrates, and are 
summarised in table 1.1. 
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Table 1.1: NICE scoring system to identify patients at risk of Re-feeding Syndrome. 
Major NICE Risk Factorsa Minor NICE Risk Factorsb 
BMI < 16 kg/m2 
Unintentional weight loss >15% in previous 3-
6 months 
Little/no nutrient intake for >10 days 
Low levels of potassium, phosphate, 
magnesium prior to any feeding 
BMI < 18.5 kg/m2 
Unintentional weight loss >10% in previous 
three to six months 
Little or no nutritional intake for >5 days 
History of alcohol misuse or drugs, including 
insulin, chemotherapy, antacids, or diuretics 
 
Other strategies for the prevention of RFS include identification of patients at risk, correction 
of abnormal serum levels before commencement of artificial feeding, provision of thiamine 
and the slow introduction and advancement of artificial feeding. A lack of thiamine can be 
caused by malnutrition, and thiamine deficiency can lead to metabolic coma and death. 
Thiamine derivatives and thiamine-dependent enzymes are present in all cells of the body, 
thus a thiamine deficiency would seem to adversely affect all of the organ systems. However, 
the nervous system is particularly sensitive to thiamine deficiency, because of its dependence 
on oxidative metabolism. Continuous monitoring of serum levels of glucose, phosphate, 
potassium, magnesium, and sodium, and observing for indications of oedema throughout 
artificial feeding is essential. If patients have one majora, or two minorb risk factors, NICE 
recommend a reduced PN prescription to lower the risk. Whilst the consequences of RFS are 
well documented, unfortunately the true incidence of re-feeding syndrome is not known, 
partly because there is no consensus on definitions and criteria for diagnosis (Stanga et al., 
2008). 
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Significance of this Study 
There is a need to examine current PN practice in New Zealand for several reasons. Firstly, 
there is a large compelling body of evidence suggesting that malnutrition prolongs length of 
hospital stay, increases inpatient hospital costs and raises the risk of complications (Chermesh, 
Papier, Karban, Kluger, & Eliakim, 2011; Jefferies, Johnson, & Ravens, 2011). Secondly, it has 
been observed that malnutrition remains prevalent in hospitals throughout developed 
countries despite increased awareness of its consequences (Pradignac et al., 2011; Webster, 
Healy, & Maud, 2009).  
Registered nurses are the primary clinicians involved in the practical aspects of care given to 
hospitalised patients. While nurses are expected to demonstrate a significant and broad range 
of nursing skills to deliver evidence-based care, nutritional support is often under prioritised in 
nursing care. Understanding why there is an under prioritisation of nutrition support might be 
the case is not fully understood, however Ross et al. (2011) identified a lack of co-ordination 
and shared sense of responsibility amongst clinicians in general, in their examination of poor 
nutritional intake in older people. 
Finally of greatest concern is that front line registered nurses tend to be the clinicians primarily 
involved in the practical delivery of PN, a complex procedure which requires specialised care 
(Bozzetti and Forbes, 2009). Seldom will these nurses have had an input in the decision to start 
PN, the type of PN that should be prescribed or how on-going management should be 
conducted. The consequences of poor management of PN care is well evidenced in the ‘A 
Mixed bag’ report conducted by the National Confidential Enquiry into Patient Outcome and 
Deaths (NCEPOD) in 2010 (Stewart, Mason, Smith, Protopapa, & Mason, 2010).  
The Mixed Bag report examined the clinical care of patients receiving PN in United Kingdom 
(UK) hospitals. The audit was initiated because of on-going evidence of malnutrition in public 
hospital patients despite a number of initiatives that had been introduced to reduce this. In 
addition one area of nutrition research that was lacking robust review was PN administration. 
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The NCEPOD study was the first of its kind to examine the actual practice of PN management 
in the UK and found that quality of care was often unsatisfactory and in some instances of 
significant concern. Only 19% of adult and 23.5% of neonate care represented good clinical 
practice (deemed to be the standard of care that the advisers would accept themselves 
(Mason, Puntis, McCormick, & Smith, 2011). Tingle (2011) described the findings as depressing, 
shocking and unsatisfactory and cautioned that the results have significant safety and legal 
implications should negligence be established in similar cases. Adequate specialist explanation 
on how PN should be given and the importance of the close monitoring required is essential to 
prevent potentially fatal complications occurring. 
Study Rationale 
Parenteral nutrition is administered in a wide range of situations throughout New Zealand’s 
public hospitals. The European Society for Parenteral and Enteral Nutrition (ESPEN) guidelines 
on PN recommends that a multi-disciplinary team is involved in all hospitals where PN is 
administered (Bozzetti & Forbes, 2009). However, in New Zealand it is known that PN is 
administered in regional hospitals with no or little specialist nutritional support input. It is 
essential that PN is appropriately prescribed, monitored and safely managed.  Yet accurate 
data on the incidence of public hospital PN usage is not currently collated in New Zealand. This 
study will be the first in-depth analysis of PN usage in New Zealand. 
The primary investigator is a Clinical Nurse Specialist working as part of a multi-disciplinary 
nutrition support team, responsible for the specialist clinical management of adult patients 
receiving PN. These patients frequently have the complexity of multiple co-morbidities. A 
significant part of the nurse specialist’s role involves co-ordinating the quality of care delivered 
to these patients in order to ensure best practice is delivered at all times. 
To this end, the primary investigator’s nutrition support team constantly evaluates their own 
practice to ensure best practice is being followed based on Australasian and International 
guidelines. Regular audits are carried out using an established and now extensive database 
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that includes comprehensive data collection on, reasons for referral, co-morbidities, weight 
history and current clinical status. Following data collection, analysis is carried out and 
reported to the interdisciplinary team, including surgeons and anaesthetists on an annual 
basis. However, actual care delivered at the bedside has not yet been audited.  
After reading the NCEPOD report, it was clear a similar and comprehensive New Zealand audit 
was needed to assess any gaps in PN practice and management. Anecdotally it was felt that 
the Waitemata district health board (WDHB) NST should perform better overall than the 
NCEPOD general findings suggested, as a truly interdisciplinary team of experts is utilised. The 
NST consists of a lead physician, a nurse specialist, a dietitian and a pharmacist.  It was agreed 
however that to be of significant worth a wider audit of practice should be conducted to 
provide a true representation of New Zealand wide PN practice, and to identify any gaps in 
practice. 
Research Question 
The question to be answered in this study is: ‘What is the current practice of PN management 
throughout the Auckland/Northern region of New Zealand?’  
The objective of this study was to investigate the current practice of PN management, 
throughout the Auckland/Northern regions public hospitals. A clinical audit process was used. 
The hospitals that participated in this study were: 
• Auckland City Hospital 
• Middlemore Hospital  
• Northshore Hospital  
• Starship Children’s Hospital 
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• Waitakere Hospital  
• Whangarei Hospital  
The primary aim of this study was to examine whether PN practice in New Zealand fares better 
under the same scrutiny as the study conducted by NCEPOD. 
Secondary aims were: to determine if New Zealand has similar results to the NCEPOD study, 
benchmarking New Zealand PN practice against the ESPEN/AuSPEN and NICE guidelines, and 
to ensure the data collection methods used were appropriate for the New Zealand context. 
Organisation of the Thesis – Chapter Overview 
Chapter 1 - This chapter introduced the reader to the focus of the regional audit planned and 
examined some of the specific issues related to PN management. It began with an introduction 
to PN, its use in the context of nutrition support and some of the potential complications 
associated with its use. Finally the researcher’s background and interest in the subject were 
also outlined.  
Chapter 2 - Reviews key literature related to PN care. The literature search strategy is provided 
as well as an overview of the main literature found. The chapter discusses the ‘Mixed bag’ 
report in more detail as well as introducing the reader to the guidelines used in the clinical 
audit carried out. Any gaps in the literature are presented and a research question formulated. 
Chapter 3 - Presents the audit process, as well as the methodology and methods used in this 
study. A review of the rationale as to why the chosen ethics process was followed is given, and 
other ethical considerations, rigour and trustworthiness of the study are reported. The data 
collection methods are also included in this chapter.  
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Chapter 4 - Presents how the data were analysed and the details the findings of the study. 
Chapter 5 - Discusses the study findings, whether the aims of the study were achieved and the 
challenges and limitations of the study. This chapter concludes with further recommendations 
based on the results of this study. 
Summary 
Parenteral nutrition is essential nutritional support for some patients and its safe 
administration is one of the many skills that nurses require. In order to be able to identify if 
there are any remediable factors and improve the overall quality of care for patients, a clinical 
audit of current practice is necessary. The present study aimed to replicate the UK NCEPOD 
study.  No clinical audit of PN management has been conducted in New Zealand to date. 
The 2010 UK NCEPOD report ‘A Mixed Bag’, identified significant concern in the practice of PN 
management. Identifying the areas of concern and increasing awareness of the concerns 
highlighted in this report should result in improved patient care and greater safety in the 
administration of PN. 
This thesis aims to critically examine the current practice of PN management throughout the 
Auckland/Northland region ensuring that the study methods as replicated from the NCEPOD 
study are transferable in the New Zealand population. Its secondary aim is to support the 
hypothesis that there is significant opportunity to improve the practice of parenteral nutrition 
which will result in improved patient outcomes. 
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2. Literature Review 
Introduction 
The benefits of PN are widely acknowledged, however it is accepted that the potential for 
serious complications mean that it is a complex therapy to administer. In addition to the well 
documented risk of complications associated with its use, PN is also a costly therapy to 
administer. In order to prevent complications occurring, appropriate and safe use of PN is 
essential. 
To evaluate the current evidence on the management of PN, a search of published literature 
was carried out. Reviewing published literature is essential to uncover what is already known 
about the subject and to identify other studies that may have relevance to the audit planned. 
Efficiently searching literature is a critical part of conducting research (Foote, 2009). Searching 
the published literature on PN studies should eliminate the risk of repeating or replicating 
previously published research, or providing no new information.  
This chapter presents the search strategies used to identify any previous research undertaken 
related to PN care. The literature reviewed will be discussed focussing on the themes that are 
examined in this study: indication for PN, type of PN, prescribing PN,  catheter choice, insertion 
and care, PN associated complications and the availability and role of nutrition support teams. 
An overview of the clinical practice guidelines (CPG) that would be used to inform best practice 
for this audit is discussed. Finally, the NCEPOD study will be discussed in detail as the current 
study aims to replicate the methods used in NCEPOD.  
Literature Search Strategy 
Several search engines were chosen to identify research relevant to the administration and 
management of PN. These were, Medline, the primary database for medicine, nursing, 
veterinary medicine, biomedicine and other allied health fields. Scopus, this database provides 
broad international coverage of journals in health sciences. Finally CINAHL—the nursing and 
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allied health database covering all aspects of nursing, health education, occupational therapy, 
social services in health care, and other related disciplines from 1983. These search engines 
were chosen as they produce a broad range of results from all disciplines relevant to the topic. 
The search fields were parenteral nutrition AND nursing, parenteral nutrition AND/OR 
management, parenteral nutrition AND complications, nutrition support teams AND parenteral 
nutrition. 
Medline yielded 732 articles on parenteral nutrition and nursing, and five articles on 
parenteral nutrition and management. These articles were then limited from 2005 to date and 
English articles only. This reduced the results to 91 articles, seven of which were selected as 
relevant PN related studies, as they examined the practice of PN management. Scopus 
provided 63 articles using the same criteria/limitations; eight were selected as relevant. 
CINAHL plus did not identify any relevant new literature not found by either Medline or 
Scopus. Articles were limited to these dates as it was felt recent research was required in order 
to make comparisons to current practice, however, as very few PN studies were found, 
references for each article chosen were manually examined and retrieved if found to be 
specific studies examining PN management, even if they were outside the dates initially used.  
Finally, Google scholar was used to review citations of the chosen articles examined and these 
were also manually searched. These searches included some older articles which the author 
felt were of interest on the subject of PN management. 
A manual search of the international Journal of Parenteral and Enteral Nutrition (JPEN) and 
Clinical Nutrition was also conducted. These journals were chosen as they are internationally 
recognised by clinicians in the field of nutrition support as being at the forefront of nutrition 
research. JPEN were also found to have published all of the ESPEN guidelines that had been 
produced in order to guide clinicians on the safe use of PN. 
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Guidelines 
Several affiliated professional organisations are considered to be at the forefront of PN 
expertise, all of which have produced CPGs outlining safe use of PN available to inform the 
clinician. These include: the British Society of Parenteral and Enteral Nutrition (BAPEN), the 
American Society of Parenteral and Enteral Nutrition (ASPEN), the European Society of 
Parenteral and Enteral Nutrition (ESPEN) and the Australasian Society of Parenteral and Enteral 
Nutrition (AuSPEN). 
The ESPEN guidelines are a collection of individual guidelines outlining recommended best 
practice in specific clinical situations, central venous access devices, as well as general nutrition 
support recommendations. These ESPEN guidelines include; 
? Parenteral Hepatology (Plauth & Schütz, 2011) 
? Parenteral Nutrition: Surgery (Braga et al., 2009) 
? Parenteral Nutrition: Pancreas (Gianotti et al., 2009) 
? Parenteral Nutrition: On Cardiology and Pneumology (Anker et al., 2009) 
? Parenteral Nutrition: Non-surgical oncology (Bozzetti et al., 2009) 
? Parenteral Nutrition: Intensive care (Singer et al., 2009) 
? Parenteral Nutrition: Geriatrics (Sobotka et al., 2009) 
? Parenteral Nutrition: Gastroenterology (Van Gossum et al., 2009) 
? Parenteral Nutrition: Adult Renal Failure (Cano et al., 2009) 
? Parenteral Nutrition of the European Society of Paediatric Gastroenterology, 
Hepatology and Nutrition (ESPGHAN) (Koletzko, Goulet, Hunt, Krohn, & Shamir, 2005) 
? Parenteral Nutrition: Central Venous Catheters (access, care, diagnosis and therapy of 
complications) (Pittiruti, et al., 2009)  
? Parenteral Nutrition: Present status and perspectives for future research (Bozzetti & 
Forbes, 2009) 
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The CPG produced are intended to be a guideline for the safe and efficient use of PN. 
However, it is well recognised that such guidelines are not able to fully capture the 
complexities of all possible clinical situations, patient pathologies, and the variability in 
clinician’s professional practice or governing organisations. They do however aim to at least 
provide a framework to guide clinicians in prescribing and administering PN safely to patients 
requiring this complex therapy. 
NCEPOD published their extensive audit of PN care in 2010, which examined PN management 
in all public hospitals in the UK; the study presented here aims to replicate NCEPOD’s study. A 
criticism of the NCEPOD study from local clinicians in New Zealand was the lack of explicit 
documentation demonstrating that evidence based guidelines were used in the review of 
cases. Evidenced based medicine can be defined as the conscientious, explicit and judicious 
use of current best evidence in making decisions about the care of individual patient (Sackett, 
Rosenburg, Gray, .Hayes, & Richardson, 1996). The Australasian Society of Parenteral and 
Enteral Nutrition have adopted the ESPEN guidelines; hence the ESPEN guidelines will form the 
basis for the audit of practice of PN throughout New Zealand described in this study.  
The quality and strength of the evidence supporting the ESPEN CPGs has been graded by the 
Scottish Intercollegiate Guidelines Network (SIGN) and the Agency for Health Care Policy and 
Research. This grading is based on a hierarchy of the evidence that has been produced, 
informing the guidelines produced. Level Ia evidence, such as meta-analyses of randomised 
clinical trials translated as a grade A recommendation.  Level IIa, IIb and III evidence was 
defined as at least one well-designed controlled trial without randomisation, a well-designed 
comparative or case- controlled studies (Grade B recommendation). Level IV evidence was 
defined as expert opinion or clinical experience of respected authorities (Grade C 
recommendations) (Bozzetti & Forbes, 2009).  
A limitation identified when producing these CPGs is the lack of Grade A evidence or even 
Grade B evidence in scientific literature. This is due in part to the difficulty to ethically justify 
randomised controlled trials that might with-hold or deny nutrition support to those most 
clinically in need. Indeed the ESPEN CPGs identify that 56% of the recommendations made are 
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based on expert opinion and clinical experience (Grade C). However, the ESPEN CPGs do seem 
however to have been robustly reviewed, involving 11 international committees, each co-
ordinated by a chairman, comprising 87 experts from 16 European-Mediterranean countries. 
Bozzetti (2009) stated that clinical practice guidelines have been proven to be effective in 
changing clinical practice and improving outcomes, including improved patient selection, 
quality of life and minimisation of complications. Comparable to research informing CPGs, 
most of the studies found on PN practice in this literature review are observational surveys, 
relating to Grade B or C evidence. 
A second limitation of the ESPEN guidelines is that they do not include specific guidelines on 
the management and prevention if RFS, which is a well-recognised potential complication of 
PN. Therefore, the NICE (2006) CPG recommendations for identifying patients at risk of RFS 
were used as the standard to audit against, in this study (An overview of these guidelines was 
provided in chapter 1, p 9). 
Review of the Literature 
Indication for PN 
Enteral or oral nutrition should always be the first choices in providing specialist nutrition 
support to those patients who are malnourished or who are at risk of malnutrition (Phillips & 
Ponsky, 2011). Using the oral/enteral route has been shown to maintain gut function and 
promotes the immunological function of the intestine (Sudakin, 2006).  Parenteral nutrition 
should be reserved only for those with a proven intestinal failure through which no other route 
for nutrition is available or appropriate (Bozzetti & Forbes, 2009). This includes patients with 
irreversible intestinal failure or who have had a temporary non-functioning gut for 7-10 days or 
who are expected to have a non-functioning gut for 7-10 days.  
Early research demonstrates that inappropriate use of PN has been an on-going issue for some 
time. For example, Trujillo et al. (1999) found that only 56% of PN administration that was 
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started without NST consultation was appropriate in accordance to the ASPEN guidelines. 
However, this increased to 82% after a voluntary NST consult service was created. Maurer 
(1996) also reported similar findings when they completed a prospective study of 50 
consecutive patients that were given PN in a 487 bedded community teaching hospital. They 
evaluated the appropriateness of PN use and found that all fifty patients received 469 days of 
PN in total, 49.7% of which was deemed to be avoidable (43% medical vs. 2% surgical). When 
formal approval for PN was introduced, PN days were reduced from 500 to 100 days per 
month again demonstrating a reduction in costs when a NST was present. However, despite 
guidance for the appropriate use of PN, further research consistently demonstrates that it is 
still often used inappropriately without the support of a NST. 
Dellegge et al. (2007) found in his single centred prospective study of 139 surgical PN episodes 
that 40% of all PN cases were deemed to be inappropriate in accordance to the ASPEN 
guideline. However, the hospital in which this study was conducted actually had a NST 
available for voluntary consultation which is noted to be of concern. All patients started on PN 
were seen by a registered dietitian or a pharmacist with clinical nutrition expertise. However 
neither the dietitian nor pharmacist was directly responsible for the ordering of PN; this was 
done by the lead clinical team caring for the patient, demonstrating again a lack of compliance 
with CPGs. 
Dellegge performed a later collaborative study with Martin (2011), who reported similar 
findings to his 2007 study discussed previously, when 278 randomly selected cases from four 
different tertiary hospitals were examined. Registered dietitians collected retrospective and 
prospective data over a three month period and found inappropriate PN use in 32% of cases. 
This study also highlighted the cost of inappropriate PN use, which resulted in a high cost of 
approximately $138,000 USD ($168,890NZD) of avoidable hospital costs.  
However, both of the studies by Dellege are limited in their study design as they rely on the 
individual clinician’s interpretation of inappropriate use. In addition, whilst the later study by 
Dellege examined randomly selected cases, there was no requirement to evenly match cases 
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by diagnosis or service. Therefore, it was unclear as to whether there was over or under-
representation of particular diagnoses or services. Thus it was difficult to generalise the 
findings of these studies to all PN users in general practice. 
Type of PN prescribed 
All of the ESPEN guidelines state that patients requiring nutritional support must be screened 
to determine their current nutritional status and malnutrition risk. They also state that 
screening should include an evaluation of weight (current and history of weight loss/gain); 
metabolic functioning particularly levels of pre-albumin, sodium, potassium, magnesium and 
glucose levels, fluid status and anthropometric measurements.  
Parenteral nutrition prescriptions need to be formulated to meet the individualised 
requirements of the patient. Although requirements can be calculated using standard 
international reference ranges for normal physiological requirements, the clinician prescribing 
PN needs to have a clear understanding of age, disease state, organ functioning, metabolic 
condition and medication usage as well as how to revise requirements accordingly. 
Assessment of those patients who are deemed to be at nutritional risk is an important 
component of initial nutrition screening for PN. ASPEN’s practice management task force 
(2010) surveyed all ASPEN members (M. DeLegge et al., 2010). There were 698 respondents 
that provided partial data and 200 surveys were completed which included answers to specific 
NST questions. The primary aim was to evaluate the state of nutrition support practice and 
utility of a NST in clinical practice. Forty two per cent of respondents had a NST, and 27% of 
NSTs included a nurse; however this was the least represented member in teams after 
pharmacists, dietitians and physicians. In only 40.5% of surveyed hospitals did all members of 
the NST perform nutritional assessments; these were completed predominately by dietitians in 
91% of cases.  
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A cross-sectional survey of PN practice in acute-care adult hospitals across Australia was 
conducted by Ali, Chapman-Kiddell and Reeves (2007). Surveys were posted to 103 hospitals 
with a covering letter explaining the intention of the survey. A total of 67 hospitals (65.7% 
response rate) were included. The survey was completed by a health professional responsible 
for the delivery of PN in their hospital. Those hospitals with a PN team (n=27) reported that in 
over half of the cases (n=15, 55.6%) the NST determined the patients’ suitability for PN, 
whereas for a quarter of the hospitals (n=7) determination of suitability was a combined 
decision between the NST and the referring medical unit. Almost all of the hospitals surveyed 
(n=66, 98.4%) reported that they assessed biochemical parameters before commencing PN.  
Prescribing PN 
Prescribing of PN is a complex issue requiring expertise and knowledge of all the components 
included and subsequent effects of administration (Mirtallo et al., 2004).  Mirtallo’s 2003 
survey of PN practice (which was one of the few multi-centred studies found) was driven by 
the American Society of Parenteral and Enteral Nutrition (ASPEN) and aimed to provide an 
overview of the variance and consistency of safe PN prescribing in all health care settings. They 
had 667 responses mainly from hospitals (85%) and found that problems in prescribing PN 
often occurred. Prescriptions were predominantly the responsibility of physicians however 
pharmacists and dietitians were often involved, with pharmacists frequently ‘overseeing’ the 
prescriptions. Fifty five per cent of respondents dealt with 0-10 PN prescriptions daily whilst 
15% had more than 30 PN prescriptions daily. Orders needed to be clarified <25% of the time 
for 88% of respondents and <10% of the time for 61% of the respondents. The most common 
reasons for PN orders requiring clarification were macronutrients prescribed, incorrect PN 
volume, content, illegible prescribing, incompatibility of components prescribed, nutrients 
prescribed outside the normal range, or the infusion rate not being prescribed. Fifty six per 
cent of respondents reported adverse events in the previous 2 years, 64% of which required no 
treatment or else increased monitoring was required. Of concern was the significance of harm 
reported, these were classified as: temporary (13%, n=61 responders) or permanent (2%, n=7 
responders), near death (3%, n=16 responders) or death (2%, n=7 responders). 
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Intravenous fluids should be prescribed based on knowledge of the clinical effects that they 
will have on the patient, taking particular caution to assess the sodium, chloride, potassium 
and water requirements. A common issue when PN is being administered is the additional 
fluids prescribed; often by junior doctors who lack knowledge about the actual fluids they are 
responsible for prescribing as well as the subsequent consequences such as fluid overloading 
(Powell-Tuck et al., 2008). 
Catheter Choice, Insertion and Care 
Whilst PN is generally administered centrally, it is often given peripherally in some centres. 
Anderson et al. (2003) undertook a review of clinical trials relating to peripheral PN (PPN) use 
in adults. They found that PPN accounted for almost 20% of all PN administered in the UK and 
showed that in the absence of consensus guidelines, there was wide variance in practice. It 
concluded that PPN was an option for nutrition support if used appropriately. Peripheral PN is 
indicated in patients that are expected to require PN for a short period and also when nutrient 
solutions are being used in which the osmolality of the nutrient solution does not exceed 
850mOsm/L.  This avoids the risks associated with CVCs such as infection, simplifies nursing 
care, reduces costs significantly and may prevent the delay in initiation of nutrition support. 
However PPN is associated with a higher incidence of peripheral thrombophlebitis and is not 
suitable for patients with substantial fluid requirements, those with high output fistula (due to 
the increased requirements of replacement electrolytes therefore increasing Osm/L), or for 
those with suitable central access that could be used for PN (Osm/L (osmolarity) refers to the 
concentration of a solution in terms of osmoles of solutes per litre of solvent- the higher the 
Osm/L, the more concentrate the solution). 
Catheter migration is a known complication which can occur following insertion (Vesely, 2003). 
Kowalski’s (1997) prospective study evaluated the change in position of chest wall central 
venous devices inserted for chemotherapy and found migration was a common event 
occurring in 49/50 patients. The carina was chosen as the reference point for measurement in 
this study, with differences on immediate supine position and post procedure (within 24hrs) 
chest x-rays measured to determine migration. Although it is thought that left sided catheters 
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may demonstrate greater risk of migration due to the longer intravascular course compared to 
those inserted on the right, Kowalski did not find that this was statistically significant in this 
study, with right sided catheters migrating an average of 2.7cm +/- 1.9cm and left sided 
catheters migrated an average of 3.2cm +/- 2.1cm. A variety of catheters were used in their 
study, none of which demonstrated a statistically significant increase in the rate of catheter 
migration.   
However, a study by DeChicco (2007) demonstrated a statistically significant occurrence of 
malpositioning when peripherally placed central catheters (PICC) were used in their clinic 
compared with other venous access devices such as Hickman lines, Groshong lines and 
implanted ports (34.2% vs. 9.0%; p<001). It should be noted that there were limitations with 
the study by DeChicco et al. (2007), which aimed to determine the prevalence of improper 
central access device tip position. A prospective study was conducted of 138 catheters in 124 
adult patients with long term central venous access devices due to receive PN. The 
recommendation made in the ASPEN guidelines for catheter tip position to be in the superior 
vena cava adjacent to the right atrium was followed. However, their use of central venous 
access devices implies practice in direct contrast to another of ASPEN’s recommendations. 
ASPEN state that infection complications are reduced when catheter access devices are 
dedicated solely for PN use or the designation of one port solely for PN use if a multi-lumen 
device is being used (Mirtallo, et al., 2004). The median catheter duration was 1.6 months in 
this study implying previous accessing of the devices, therefore considerably increasing 
infection risks in this situation. The second point of interest is that evidence suggests that PICC 
lines are associated with reduced rates of infectious complications in comparison to other 
central venous access devices (Maki, Kluger, & Crnich, 2006). However, if PICC lines are also 
associated with greater incidence of migration, then further study is essential to determine 
what the safest central venous device for PN use is (Cowl et al., 2000). Whilst the proposed 
study will examine choice of catheter, it is not the intention to explore this dichotomy further 
in this thesis. 
ESPEN have specific recommendations for reducing the risk of catheter related infections 
including, catheter choice, hand-washing, barrier precautions during insertion, disinfection, 
regular changing of infusing sets and education for staff. All are intended to inform clinicians of 
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current recommendations for central venous access device care, however evidence suggests 
that these are sometimes not adhered to. 
Despite CPGs, PN practice is often variable and does not adhere to recommendations made 
(Pittiruti, et al., 2009). Likewise the practice of CVC care also appears to vary considerably. A 
small prospective cross sectional nursing survey of 14 ICUs throughout Australia were surveyed 
about their infection control practices when using CVCs and responses compared to evidence 
based guidelines (Rickard, Courtney, & Webster, 2003). The study found a wide variety of 
responses demonstrating inconsistency in infection control practices. This nursing based study 
has a number of limitations. Firstly, each ICU included was telephoned and a questionnaire 
was completed by the researcher based on responses to questions asked. The person 
identified from each ICU was the charge nurse or senior nurse on duty. The author of the study 
noted that the responses given may be the opinion of the nurse questioned rather than 
standard practice in the unit in which they were working. Secondly, responses may have been 
based on what was considered to be the ‘correct’ answer.  However, the study confirms that 
there is some variability in the infection control to CVC care, with some instances of non- 
adherence to CPGs.  Why this should be the case was not investigated or identified if known.  
PN associated Complications  
Catheter-related infection is probably the most common serious potential complication 
associated with PN as the high concentration of glucose within the PN makes it an ideal 
environment for the colonisation of microbes. Beghetto et al. (2005) conducted a single centre 
concurrent cohort study of adult patients with a CVC, with or without exposure to PN. The aim 
of the study was to evaluate PN as a risk factor for CVC related infection in a general university 
hospital. For each patient receiving PN two others were randomly selected on the same day, 
one from the same ward and one from ICU. One hundred and fifty three patients were studied, 
28 of which developed a CVAD infection. A multivariate cox analysis was carried out which 
demonstrated that PN was the only risk factor for CVAD infection (RR =3.30%; 95% CI, 1.30-
8.34; p=0.012). Malnutrition, length of hospitalisation and sustained hyperglycaemia were of 
no significance. 
- 28 - 
 
Hyperglycaemia is a relatively common complication for patients receiving PN (Lin, Lin, Lee, 
Ma, & Lin, 2007). It is associated with increased infection rates as well as fluid and electrolyte 
imbalances. Studies demonstrate a correlation between PN, blood glucose levels and 
morbidity and mortality (Cheung, Napier, Zaccaria, & Fletcher, 2005; Pasquel et al., 2010).  
Cheung’s (2005) retrospective single-centre study of 111 patients, (122 PN episodes) analysed 
outcome measures for patients receiving PN who developed hyperglycaemia. Increased blood 
glucose levels were associated with a significantly increased risk of cardiac complications 
(p=0.02), infection (p=0.01), systemic sepsis (p=0.05), acute renal failure (p=0.05) and death 
(p=<0.01). When data were examined by quartiles of blood glucose levels, patients in the 
highest quartile (>9.1mmol/L) were 10.9 times more likely to develop complications than 
patients in the lowest quartile (<6.9mmol/L) and the risk of developing any complication was 
4.3 times higher (p=<0.01).  
Whilst RFS is known to occur, Wagstaff (2011) in her survey of London based dietitians, 
suggests there is a universal lack of knowledge and/or a lack of compliance with the NICE re-
feeding guidelines. Anonymous surveys distributed to dietetic service managers across all 
acute, community and mental health trusts in the London region yielded a 30.8% response 
rate. One hundred and sixty eight dietitians responded from 33 of the 62 NHS trusts surveyed. 
Similarly the patient identified at risk of RFS was fed initially at a reduced rate of 12.7kcals/kg 
suggesting lack of compliance with the NICE guidelines which recommends a starting rate of 5–
10 kcal/kg depending on the patient’s risk.  
Availability and role of Nutrition Support Teams  
Organised NSTs are associated with improved patient outcomes, decreased length of 
hospitalisation and improved cost effectiveness (Russell, Andrews, Brewer, Rogers, & Seidner, 
2002). Russell et al. (2002) published standards for specialised nutrition support and identified 
that the function of nutrition support services is to assess and manage patients determined to 
be nutritionally at risk. They recommended that the NST should include a physician, nurse, 
pharmacist and dietitian who have undertaken specialist training in the administration of 
specialised nutrition support.  
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DeLegge et al. (2010) also suggests the benefit of a multi-disciplinary NST stating that 
“individually each member of the NST plays an important role in improving the nutrition status 
of patients, but the safety and efficiency of care are enhanced when they collaborate as a 
team”.  Labour costs constitute the greatest percentage of hospital expenditure. Nonrevenue 
producing and labour intensive NSTs have been frequently identified as targets for cost cutting 
(Bines, 2002). This is despite repeated evidence that specialised nutrition teams increase the 
quality of care and decrease the complications of nutrition support.  
Kennedy et al. (2005) demonstrated that there was a reduction in costs as well as complication 
rates in the adult population when a NST was utilised. Comparative data was collected for two 
consecutive years – a retrospective pre-NST and a prospective NST year. Pre-NST there were 
82 PN episodes (54 patients = 665 PN Days) and, with a NST there were 78 PN episodes (75 
patients = 752 PN days). This single centre study found that catheter-related complications 
occurred in 71% of PN episodes compared with 29% when a NST was present (3 infections per 
100 PN days, p=<0.05). Furthermore, 133 NST referrals were made however only 78 were 
provided PN, resulting in cost savings in 55 patients.  
Evidence suggests that the employment of a nutrition support nurse specialist can significantly 
reduce the incidence of complications associated with PN as well as the costs associated with 
inappropriate PN usage. Kennedy (2005) conducted a study examining the tangible cost 
savings made by having a dedicated nutrition support nurse. This study was carried out by the 
Leicester Royal Infirmary in the UK after a nutrition support nurse role was established in 1999, 
working in all adult areas of a university hospital. Comparative data about all patients given PN 
were collected for two consecutive years (a retrospective pre-NST year and a prospective NST 
year). The study demonstrated that despite the number of PN days increasing with an NST, 
tangible cost savings of £50,715 (105,981NZD) were demonstrated within the NST year by 
avoided PN episodes and a decreased incidence of catheter related sepsis.  
Goldstein (2000) conducted a quasi –experimental, reversal on-off, retrospective study of the 
medical and financial costs associated with termination of a nutrition support nurse (NSN). 
- 30 - 
 
They aimed to determine the effect of termination of a NSN responsible for patients receiving 
PN. This study examined 1,093 patients that received PN from fiscal years 1992-1998. The 
study compared the periods in which a NSN was employed to the period in which the role was 
disbanded and later re-instated. Costing’s were estimated based on actual costs, cost of 
inappropriate use and as a result of complications incurred. This study found increased 
inappropriate usage in the period when no NSN was in post, a decrease in costs when the NSN 
was present and an increase in sepsis when no NSN was present.  Although this was a single-
centre study its strength was that it focused on the NSN role specifically. 
The Mixed Bag Report 
The NCEPOD organisation is an independent UK organisation run and overseen by the 
healthcare profession. Their aim is to undertake independent reviews of clinical practice and 
they have published over 28 reports on a range of diverse topics. These include: care of 
patients admitted to hospital as emergencies, care of the seriously injured patient, as well as 
specific disease and service topics such as sickle cell disease, thalassemia and therapeutic 
endoscopy. The aim of the ‘Mixed bag’ PN study was to examine the practice of PN 
management throughout public hospitals in the UK, and to identify remediable factors 
(Stewart, Mason, & Protopapa, 2010). The study was designed and carried out by a multi-
disciplinary group of experts who also contributed to the review of the findings. These 
included gastroenterologists, paediatricians, dietitians, pharmacists, nutrition nurse specialists, 
a lay representative and a scientific advisor.  
All National Health Service hospitals in England and Wales and Northern Ireland, hospitals in 
the independent sector and public hospitals in the Isle of Man, Guernsey and Jersey were 
expected to participate in the study. Patients that had received PN as an inpatient between 1 
January 2008 and 31 March 2008 were included. Patients receiving home PN were excluded.   
The study used three questionnaires to collect data. The first two included, a clinician patient 
care questionnaire used for individual patients and the other, an organisational questionnaire 
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was used for each hospital. The patient questionnaire was completed by either the clinician 
responsible for the patient at the time of PN administration, or if not, by the clinician 
responsible for the PN itself. The organisational questionnaire was based on the hospital 
policies and protocols for PN and the availability of NSTs. On completion of the patient 
questionnaire, clinical records were copied and all data was returned to NCEPOD. Advisor 
assessors then examined all cases and completed a third questionnaire based on their 
interpretation of the care provided. Finally an overall grade of care was provided. 
A total of 5,527 patients from the 218 hospitals included were identified. The study sample 
was reduced to 3,305 when the number of patient per consultant was limited to two. Also 
those patients for whom a PN prescription was written but was not commenced on PN were 
excluded. For a further 167 cases NCEPOD were notified that the questionnaires could not be 
completed. Reasons for this included case notes being lost, the consultant having left the trust 
or wrongful identification. For the remaining 3138 patients included, patient questionnaires 
and/or case notes were received for 1948 cases (62%).  
The findings were considered to be ‘deeply depressing’ by the advisors who found that too 
often the quality of care was unsatisfactory. Room for improvement was found to be 
predominantly in the areas of clinical care where cases were identified as receiving care that 
was considerably less than satisfactory. A number of worrying findings were identified: PN 
being administered for an inappropriate indication, inadequate clinical assessments, 
inadequate monitoring of patients receiving PN, poor biochemical/metabolic monitoring, 
having additional IV fluids/inappropriate volumes and types of fluids. 
The value of peer review of the cases studied has been identified as both strength and a 
weakness of studies conducted by NCEPOD including this PN report. Stewart et al. (2010) 
stated that ‘peer reviews of these processes on a case-by-case basis by a multidisciplinary 
group of healthcare professionals who work ‘at the coal face’ of PN care is a powerful tool’. 
Conversely they recognised that the report only reflects the opinions and values of the expert 
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advisors based on the information received. In addition, there is the assumption made that the 
findings can be generalised to reflect the current state of PN across the whole of the UK. 
Significance of the Literature for this Study 
The studies discussed demonstrate that despite the existence of CPGs to guide clinicians on 
the safe use of PN, care is widely variable between institutions with little evidence that CPGs 
are consistently used. Why this may be the case is unknown. It is intended that this study will 
establish whether New Zealand PN care is similar or if in fact differs, from that of our peers in 
other countries. If it is found that our practice is similar it is imperative that further research is 
conducted to establish what the barriers to clinicians using the CPGs available are. 
It is recognised that nutrition support research can often be limited to small studies with 
limited power. In order to get significant results to inform the wider nutritional knowledge 
base larger multi-centred collaborative studies are essential (Wischmeyer, 2008). Although this 
thesis presents phase one, a fraction of PN practice in New Zealand, examining PN in the 
Auckland/Northland region only, it is hoped that phase two which will be completed at a later 
date and will examine PN care throughout all of NZ, will generate more significant findings. 
Summary 
This chapter has presented an overview of the current literature on the care and management 
of PN. The literature review has demonstrated that PN is often administered inappropriately. 
Complications can frequently occur without adequate monitoring and processes in place to 
prevent and identify complications early. Parenteral nutrition care is often not co-ordinated by 
clinicians that have specialist knowledge and expertise required to administer it safely.  
The studies presented have illustrated that significant improvements in patient care are often 
demonstrated by establishing nutrition support specialists trained in the care of PN; it has also 
shown that considerable cost savings can be made by the implementation of a NST. The 
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following chapter will outline the clinical audit framework that informed this study. It will 
discuss the audit cycle, as well as some of the strengths and limitations of the research method 
chosen for this study. 
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3. Methodology and methods 
Introduction  
This chapter begins by describing the research design and the methods used for this study. 
Secondly, it will give an overview of the approach and rationale for the methodology chosen. 
Thirdly, it will discuss methods for participant selection, the research setting, data collection, 
and data analysis. Fourthly, the ethical considerations involved with this study are discussed. 
Finally, the process of establishing and maintaining rigour and trustworthiness will be 
considered.  
To examine the current use of PN throughout the Auckland/Northern region, a clinical audit 
was conducted. The aim of the audit was to identify the current management of PN care in the 
Auckland/Northland region, examining specific themes, indication for PN, type of PN, 
prescribing PN, catheter choice, insertion and care, PN associated complications and the 
availability and role of NSTs. A secondary aim was to determine if the NCEPOD methodology 
used was transferable in the NZ population. This chapter will introduce the reader to the 
clinical audit process and will explain how audit can contribute to understanding how PN care 
is currently provided and any associated benefits and/or limitations of audit.  
Research Methodological Framework 
Quality improvement is the responsibility of all health professionals and is best done using a 
multi-disciplinary approach; nurses are often expected to participate in quality initiatives 
within their workplaces (Bowie, Bradley, & Rushmer, 2012). Clinicians need to demonstrate 
the effectiveness and efficiency of service provision, focusing on ensuring evidence based 
practice is at the cornerstone of care delivery.  This requires the examination of care through 
research, service review and audit activities. Differentiating between these activities is 
complex,  however Mawson et al. (2007) offer the following simple rules for defining the 
activities of research, audit and service review (See Table 3. 1). 
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Table 3.1 Defining activities of research, audit and service review 
Activity Simple rule 
Clinical Audit Measures existing practice against evidence-based, best practice, 
clinical standards.  
Research Generates new knowledge where there is no or limited research 
evidence available and which has the potential to be generalisable 
or transferable.  
Service Review Incorporates both service/practice development and 
service/practice evaluation. Service/practice development – 
introduces a change in service delivery or practice for which there 
is evidence derived from research or from other health/social care 
settings that have already introduced and evaluated the change. 
New developments should always be evaluated. Service/practice 
evaluation– evaluates the effectiveness or efficiency of existing or 
new service/practice with the intention of generating information 
to inform local decision making. This type of activity has 
sometimes been referred to as a clinical effectiveness study, 
baseline audit, activity analysis and organisational audit. 
Ashmore and Ruthven (2008) also offer the novice clinical investigator very clear definitions 
between research and clinical audit. Both research and audit are systematic processes that 
involve statistical analysis and topic selection, and both can lead to change in clinical practice. 
However there is a definitive difference. Research attempts to derive generalisable, new 
knowledge by addressing clearly defined questions with systematic and rigorous methods. 
Clinical audit on the other hand investigates whether best practice, as defined by clinical 
research, is being implemented.  
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Hill and Small (2006) characterise the difference between research and audit as “research is 
finding out what you ought to be doing; audit on the other hand is whether you are doing 
what you ought to be doing” (p.99). At present the most widely used definition was developed 
ten years ago by NICE. 
NICE (2002) defines clinical audit as a quality improvement process that seeks to improve 
patient care and outcomes through systematic review of care against explicit criteria and the 
implementation of change. Aspects of the structure, processes and outcomes of care are 
selected and systematically evaluated against explicit criteria. Where indicated, changes are 
implemented at an individual, team, or service level and further monitoring is used to confirm 
improvement in healthcare delivery. 
Clinical audit is one of the key elements of clinical governance, which has been acknowledged 
as the driving force behind National Health Service (NHS) reform since the government white 
paper outlined a new style NHS in the UK in 1997 (Taylor & Jones, 2006).  It is described as a 
framework through which organisations are accountable to continue to improve the quality of 
the service and safeguard high standards of care by creating an environment in which 
excellence in clinical care would flourish. The processes involved in clinical audit are often 
represented diagrammatically; one of the most widely adopted within the United Kingdoms’ 
NHS as well as New Zealand’s Ministry of Health (MOH) is the Plan-Do-Study-Act (PDSA) cycle 
(2002). See Figure 3.1  
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Figure 3.1: Audit cycle 
 
 
Boult and Maddern (2007) identify several factors which enable successful audit. These include 
mechanisms to make data collection easy, effective information technology, dedicated staff 
and protected time to release the burden on clinician’s clinical workload. As well as these, a 
supportive organisational environment, sound leadership and direction of audit programmes, 
strategy and planning of audit programmes, monitoring and reporting of audit activity, 
commitment and participation, and high levels of audit activity, which can be seen as relevant 
and to involve participants. 
However, clinical audit is not without its limitations. There is a belief that healthcare 
professionals are prompted to modify their practice, when given performance feedback 
showing that their clinical practice is inconsistent with a desirable target. Some authors have 
disputed the certainty of action, and question the effectiveness of audit and feedback in 
improving healthcare practice. The characteristics of audit and feedback that are believed to 
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lead to greater impact, are detailed planning of the audit and timely feedback following audit 
(Ivers et al., 2012). 
Bowie et al. (2012) conducted semi-structured interviews, and used focus groups to examine 
the views and opinions of clinical audit advisors from two large Scottish district health boards. 
The advisors reported that work pressures and lack of time were frequently cited as barriers by 
clinicians involved with audit activity, but believed these may hide other reasons. Bowie et al. 
(2012) found that audit is perceived to be time-consuming, an additional chore and is often 
associated with a belief in hidden political agendas driven by management.  
In order for audit to be effective, the tools and methods used for data collection must deal 
with the potential for bias arising from coverage, sampling, measurement and non-response 
errors (Boult & Maddern, 2007). An often noted criticism of the audit cycle in practice is the 
failure to complete the cycle following evaluation, by implementing recommendations for 
change and re-auditing the effects changes may have had. Without the subsequent evaluative 
re-audit, it is not possible to learn whether the quality improvements recommended have 
been made are sustainable, and what the effects of these changes on patient care are (Farrell 
& Hill, 2012).  
As discussed, clinical audit allows the clinician to monitor service delivery through the 
collection of information. It leads to an increased awareness of how things actually are, 
encourages improvement initiatives and should result in sustainable improvements in patient 
care. Clinical audit relies on the collection of data which provides information on the subject 
being audited. Prospective audit is based on the collection of information about patients 
during their process of care. It permits more reliable and complete clinical data collection since 
the data required is pre-defined and can be validated and errors corrected while the data 
collection is in progress (Schneider and Elliott, 2008, p. 181). A possible disadvantage is that 
practice may be altered if clinicians are aware that they are being observed and that data is 
being collected. Retrospective audit is generally based on review of records of discharged 
patients. This may provide information that is more representative of day-to-day practice, but 
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it is more difficult to obtain complete data on every subject in the sample. Retrospective audit 
may make use of computer databases provide the data they contain is of adequate quality. 
The investigator of this study considered conducting a prospective audit; however the 
potential for this to prompt clinicians to modify their practice was recognised, hence would 
not reflect the true state of PN management in NZ. Therefore, to examine current practice of 
PN management and to identify remediable factors, a retrospective audit was considered the 
appropriate method to meet the study aims. A key factor for clinical audit is that care provided 
is audited against specific evidence based criteria; in this study, PN care was audited against 
the ESPEN and NICE clinical practice guidelines. 
Methods 
Planning 
The project was first considered in mid-2010 subsequent to the release of the NCEPOD report 
(See pg. 27 for an overview of the NCEPOD report). A meeting was convened with colleagues 
that work in the field of nutrition support, and included representatives from local hospitals 
and PN industry providers. A review of the NCEPOD findings was presented and a discussion 
was had as to whether practice in New Zealand was likely to be any different. It was known, 
through anecdotal evidence, that PN is administered in some areas without specialist nutrition 
support, which led the group to believe that NZ may have as similarly disappointing results as  
the NCEPOD study. The consensus from the meeting was that an audit, based on NCEPOD 
methods with amendments as necessary, would be worthwhile.  
Cognisant of the commonly held criticisms of NCEPOD’s use of subjective expert opinion alone 
to determine good practice, it was felt that a study conducted in New Zealand should first 
agree the guidelines to be used as standards that local practice would be audited against. The 
comprehensive ESPEN guidelines were under review by AuSPEN at the time, and it was 
anticipated that these would be adopted as recommended best practice for Australasia. Other 
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guidelines suggested were the NICE guidelines, which are internationally recognised, however, 
these are not specific to the management of parenteral nutrition. The ESPEN guidelines were, 
therefore, chosen as the overall standard measure. However, as the ESPEN guidelines did not 
include specific recommendations on managing the risk of RFS, the recommendations given in 
the NICE guidelines for identifying patients at risk of RFS were used. The NICE 
recommendations on re-introducing feeding were also used as the standard for the audit (See 
pg. 9 for an overview of the NICE guidelines). 
There was also significant discussion amongst the group as to what the definition of RFS should 
be for the study, as although it is known to occur, agreement on the exact diagnosing features 
is lacking in published literature (Stanga et al., 2008). A clinical definition which the co-
investigator of this study has developed following another study (yet to be published) was 
accepted by the group as the standard by which cases would be audited again. Roas and 
Walmsley (2012) conducted a retrospective study of our database at North Shore Hospital in 
Auckland, New Zealand. Two hundred and ninety two consecutive episodes of PN in 272 
patients were analysed that received PN between Jan 2005 and December 2009.  Re-feeding 
syndrome was defined as ‘probable’ if there was a drop in serum phosphate combined with 
evidence of pathological development of extracellular fluid shift and ‘possible’ if there was a 
fall in serum potassium, magnesium with development of oedema (Roas, Z., Walmsley, R. 
2012, personal communication). 
It was suggested and agreed that the study should be conducted in two phases. Phase one, a 
smaller regional study, followed by phase two, a national study to be carried out at a later 
date. The initial phase one of the study would examine practice throughout the Northern 
Region District Health Boards (DHBs) of Auckland, Counties Manukau, Waitemata and 
Northland DHBs. The aim of this smaller regional study was to test the suitability of the 
NCEPOD methodology in NZ. Phase one is presented in this thesis. 
A multi-disciplinary group of six local clinicians were identified to be invited to participate in 
case reviews and to assign an overall grade of care provided. Local clinicians were chosen for 
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phase one of this study for ease of access, to enable regular meetings and to reduce any costs 
associated with the study. These clinicians were all experienced PN users; they were known 
regionally, nationally or in some cases internationally for their expertise in nutrition support. 
Many of them were members of AuSPEN and/or ESPEN, so were very well versed with the 
ESPEN guidelines. All were currently involved in the provision of clinical nutrition, education 
and research. The group consisted of both adult & paediatric gastroenterologists, dietitians 
and a nutrition nurse specialist. 
Although the primary aim was to identify current PN management in NZ, a secondary aim was 
to assess the NCEPOD methods and identify whether there were areas, such as methods of 
data capture that would need to be adapted in the NZ setting. In order to make a comparison 
between the management of PN in NZ to that in the UK, it was agreed to use the already 
validated NCEPOD data collection tools, using the three questionnaires they had developed.  
The patient care and advisor assessor questionnaires were both divided into sections 
examining specific themes of PN care; indication for PN, type of PN, CVC care, PN associated 
complications and the availability and role of NSTs.  Within each section several questions 
were asked about that specific aspect of PN care. On completion of the advisor assessor 
questionnaire, the advisors were asked to assign a final grade based on their overall 
assessment of PN care provided. The assessment grades used in the NCEPOD questionnaires 
were; good, room for improvement or less than satisfactory. Advisors were then asked to 
record a rationale for the grade assigned. 
NCEPOD were contacted for permission to use their questionnaires and we were informed that 
they produce a ‘study pack’ which includes the questionnaires on their webpage which is 
accessible for other centres to audit their own practice against - http://www.ncepod.org.uk/. 
The study protocol was framed following further consultation with a project advisory group 
comprising of the participating hospitals nutrition support teams. This thesis is based on phase 
one, the regional audit conducted.  
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To publicise the study to a wider and more diverse audience, and gain support for the 
proposed audit, endorsement was requested from the various affiliated professional bodies of 
the clinicians assisting with the study. Endorsement included publication in the professional 
journals and newsletter. Such endorsement is hoped to raise awareness of the study and 
encourage later participation in phase two of the audit. Endorsement was received from; the 
Australasian Society of Parenteral and Enteral Nutrition (AuSPEN), the New Zealand Nursing 
Organisation (NZNO), the New Zealand Society of Gastroenterologists (NZSG) and the Royal 
College of Surgeons (RCS). 
Ethical Issues & Cultural Responsibilities 
Even though audits are considered low risk activities and often do not require the same 
stringent ethical regulation as other forms of research, clinical audit must be conducted within 
an ethical framework (MOH, 2012). By definition, clinical audit should provide a beneficial 
outcome and do no harm. A clinical audit should not involve anything being done to a patient 
that is beyond the normal clinical management. For this reason, in New Zealand, clinical audit 
does not necessarily require formal ethical approval by a full human research ethics 
committee, especially when undertaken as part of academic study as is phase one of this 
study. 
All clinicians involved with an audit activity have an ethical responsibility for good study 
conduct (MOH, 2012). Investigators conducting, or involved in conducting, observational 
studies (or audit) are responsible for ensuring these studies meet ethical standards. This is the 
case whether or not ethics committee review is also required. When there is more than one 
investigator, the principal investigator has the overall responsibility for the ethics of the 
activity. The NZ Ministry of Health state that the following considerations are particularly 
important: respect for people, Māori and ethical considerations, justice, beneficence and non-
maleficence, integrity and diversity. 
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As this audit involved the collection of previously recorded information from multiple health 
care providers, an expedited application was made to the Northern X Regional New Zealand 
Health and Disability Ethics committee. The application was made for both phase one (the 
smaller regional study presented in this thesis) and phase two (a national study to be carried 
out at a later date which does not inform this thesis) of the audit. This process was appropriate 
due to the intent of the clinical audit: 
a)  A retrospective chart audit (secondary use of data) which would all be de-identified by the 
participating hospital’s local reporter and 
b) The outcomes of this investigation may potentially impact the care of future patients.  
Expedited ethics approval was granted, approval number - 16/9/11 - NTX/11/EXP/218 
(Appendix 4) 
All research should be conducted with awareness of, and with the upmost respect for Maori as 
the indigenous population of New Zealand (Hudson & Russell, 2009). Article 3 of Te Tiriti O 
Waitangi, grants all Maori the rights and privileges of British subjects, which includes access to 
healthcare services required (Tupara, 2012). Health research, including this study, will help 
improve healthcare, thus improving the delivery of healthcare to Maori. Article 2 of Te Tiriti O 
Waitangi, guarantees Maori continuance of possession of their Taonga (treasures, things seen 
and unseen), of which, good health is included. A successful outcome of this research will lead 
to improved health status for all those that require PN. While not specifically aimed at Maori, 
this study has relevance to their on-going quest for improved health status. Following 
consultation with a Maori research advisor at WDHB, it was agreed that no further Maori 
consultation was necessary for this audit as there were no specific risks that needed to be 
addressed. 
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The chief investigator of this audit is an employee of WDHB therefore the audit was also 
registered with the WDHB Awhina health campus database and the Massey University 
Accredited Ethics committee as is required for research activity.   
Data Collection 
Data were collected using the three NCEPOD questionnaires (Appendix 1). The first, an 
organisational questionnaire examining the hospital’s nutrition support practice. The second, a 
patient care questionnaire in which details of care provided were recorded for each patient. 
Finally, an advisor assessor questionnaire completed by an experienced PN user who reviewed 
the care provided and assigned an overall grade. The grades available were; good, room for 
Improvement or less than satisfactory. Both the patient questionnaire and advisor assessor 
questionnaires were divided into sections examining specific aspects of PN care, indication of 
PN, type of PN, central venous access devices, PN associated complications and availability and 
role of  NSTs. The three questionnaires were distributed to the project advisory group for 
consultation and comments. Minor adjustments were made, generally in terminology or else 
to clarify the question being asked to ensure ambiguity was avoided.  
Local Reporter 
A local reporter was recruited from each public hospital participating in the study and was 
employed within the District Health Board. The role of the local reporter was to act as a point 
of liaison with the research group and to co-ordinate the collection of data in their particular 
hospital. This person was identified as either belonging to the NST or else being directly 
involved in PN management within their hospital. The local reporter from each hospital was 
asked to gain consent through their hospital research approval processes and with their 
appropriate managers. A consent form (Appendix 2) was provided which outlined the required 
consent as well as information on the right to withdraw participation at any time. Local 
reporters were asked to provide confirmation of consultation and consent to participate in the 
study to the primary investigator.  
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Once the required approval had been given, each hospital’s local reporter provided minimal 
data set for patients of all ages that received PN during the period of January 1st to June 31st 
2011. This included age and the consultant and speciality under which the patient received PN. 
Only hospital patients were included; home PN patients were excluded even if they were 
admitted to hospital and received PN within the study period. From the initial data provided 
purposive sampling was then used to select patients that reflected a diversity of clinician and 
specialities to ensure a representative sample of patients receiving PN in public hospitals. 
Purposive sampling is a type of non-probability sampling used in research to handpick cases 
which may be typical of a population to be included in the study, based on a variety of criteria, 
that they can generate the information required (Schneider & Elliott, 2008). In this instance 
patients that had received PN in public hospitals in NZ were selected in order to examine 
current care of PN administration and management. One out of four cases was selected by the 
primary investigator and co-investigator for peer review by expert advisor assessors. 
The local reporter was then asked to complete a patient care questionnaire and provide 
detailed clinical data (which they de-identified) on each selected patient that received PN 
within the study period. If the patient selected was not managed directly by the local reporter, 
they coordinated completion of the questionnaire and the collection of de-identified clinical 
data with the appropriate clinician. Clinical data for each patient was copied and de-identified 
by the local reporter. These included clinical notes, nursing notes, nutrition notes, 
biochemistry/haematology results, fluid balance charts, observation charts, nutritional charts, 
weight chart, urinalysis, X-ray/CT results, operation notes and nutrition assessment records. 
The local reporter from each hospital co-ordinated the distribution/completion of 
questionnaires, collation of requested clinical information and acted as liaison with the main 
research team. Each participating hospital that requested was reimbursed for the printing 
costs associated with data collection. 
The local reporter also completed the organisational questionnaire which examined each 
participating hospital’s practice of PN management. The information requested in this 
questionnaire included topics such as who orders PN, where is PN manufactured and the 
availability of nutrition support teams.  
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Case Reviews 
The patient questionnaires and de-identified documents were then sent to the primary 
researcher for anonymous retrospective review by expert advisor assessors. Cases were 
assigned by the primary investigator to ensure that the expert advisor assessors were not 
given cases from their own institution to examine. The role of the expert advisor assessor was 
to critically examine the de-identified clinical data and patient questionnaire on each of the 
selected cases. Based on the care provided and in accordance to compliance to the 
recommended ESPEN/AuSPEN and NICE guidelines, an advisor assessor questionnaire was to 
be completed. There was opportunity to record free text within the advisor assessor 
questionnaires to clarify care provided. Finally, an overall grade of the care provided was to be 
given.  
A meeting was held with the invited advisor assessors to discuss their role, what was expected 
of them and a review of the questionnaire they would be completing. At this time it was 
identified that there was a lack of independent experienced paediatric and neonatal PN users 
regionally to review those cases. It was therefore agreed to suspend review of the paediatric 
and neonatal cases until the national study was conducted at a later date.  
In addition to those invited to complete expert reviews it was agreed that opinions may have 
been sought from other clinicians if more specific expert advice was necessary during analysis 
of the clinical information for each case. This would have included advice from; a clinical 
biochemist, intensivists, a general surgeon, and pharmacist. 
Reliability, Validity & Bias 
Reliability refers to the consistency of results (measurement) obtained from the audit, based 
on the control, reduction, and/or elimination of measurement error.  Validity is, the accuracy 
and appropriateness of the interpretations and inferences (evaluation) drawn from the results 
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of a measurement. Biases are systematic errors in how study subjects are selected or 
measured, which result in false inferences (Hartung & Touchette, 2009). 
Although clinical audit is often not associated with the same risks of other types of research in 
terms of ensuring reliability, validity and addressing the potential for bias, there were still 
some issues noted for this study (MOH, 2012).  
The participating hospitals chosen in phase one of the study all had a clinician or nutrition 
team that had indicated a commitment to the study in principal and were motivated to 
identify current practice within their own facilities and use the findings to improve practice 
where necessary.  It was recognised by the primary investigator that selecting these particular 
hospitals to participate in this phase one audit may introduce an element of bias to the overall 
NZ findings. It is acknowledged that the Auckland region is an area of concentrated nutritional 
support expertise with four of the participating regional hospitals reporting an active nutrition 
support team. Therefore the findings of this audit (phase one) may not necessarily be 
transferable to all patients given PN throughout New Zealand (phase two) as not all hospitals 
have a dedicated nutrition support teams in their hospitals. 
As previously described, to ensure reliability and validity for this investigation the analysis was 
underpinned by using recognised best practice guidelines. Advisor assessors were given bound 
copies of all of the ESPEN guidelines that would be used as the standard cases were audited 
against. The guidelines provide specific recommendations on how PN should be best managed 
in particular situations, recommendations on PN composition, specific disease related 
complications that may occur and monitoring required.  
The principle aim of this study was to examine the practice of PN management in the 
Auckland/Northland region, however, a secondary aim of this phase one pilot study was to 
ensure the reliability and validity of the NCEPOD data collection tools, ensuring they were 
appropriate for the NZ setting. Measures were taken to minimise risks of reliability and validity 
of the data recorded. 
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It was acknowledged that there was a possibility for bias in the data returned by the advisor 
assessors, as they may grade standards of care inconsistently between cases, as well as 
between themselves.  In order to minimise this, the author produced a ‘test case’ for 
examination by the expert advisors.  All of the advisor assessors were convened and the test 
case was given to them for review. Following completion of the review, each question and 
response was then discussed in detail to establish a consensus on the consistency expected. A 
study guideline was produced to ensure consistency in analysis of case reviews based on the 
discussion generated completing the test case. 
Advisor assessors were then asked to return their first completed case reviewed to the primary 
investigator for comparison review. Following this, meetings were held on an individual basis 
with each advisor assessor in order to discuss areas any of inconsistent completion of the third 
questionnaire. 
On completion of the study, both local reporters and advisor assessors were asked to provide 
feedback on the processes involved in the audit, questionnaires, methodology and suggestions 
for improvements needed for phase two.  
Data Analysis 
Following completion of expert peer review by the advisor assessors all data were returned to 
the author, this included the patient care questionnaires, all de-identified clinical data, and the 
advisor assessor questionnaires. Data were then entered into a secure Microsoft Office Excel 
database by the primary investigator. All data entered was double checked at the point of 
entry and once all data was entered additional checks were made by the co-investigator.  
Following data entry, analysis was completed using Excel program. Clinical audit data is often 
presented purely as descriptive statistics, representative of practice at the time of data 
collection. There is often no attempt to draw significant statistical conclusions on the data 
collected. Due to the small sample size of patients and hospitals in this study, the results are 
reported descriptively, as numerically and percentage values only. 
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Summary 
Clinical audit seeks to improve patient care and outcomes through systematic review of care 
against explicit criteria and the implementation of change. Aspects of the structure, processes 
and outcomes of care are selected and systematically evaluated against explicit criteria. Where 
indicated, changes are implemented at an individual, team, or service level and further 
monitoring is used to confirm improvement in healthcare delivery. 
This chapter has outlined audit activity, the underpinning methodology and methods used to 
complete this retrospective clinical audit. It has addressed the ethical considerations as well as 
the methods used to overcome the risks associated with bias, reliability and validity. How data 
was selected, collected and analysed is discussed. 
The following chapter will presents the results of the investigation of parenteral nutrition, 
focussing on the themes examined in the questionnaires: indication for PN, type of PN, CVC 
care, PN associated complications and NSTs.  In the final discussion chapter I will explore the 
final stage of the PDS - ACT cycle, the feedback process and the plans for re-audit following 
implementation of any recommendations made as a result of this audit. 
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4. Results 
Introduction 
Clinical audit is a quality improvement process that seeks to improve patient care and 
outcomes through systematic review of care against explicit criteria and the implementation of 
change. In order to examine the current practice of PN management throughout New Zealand 
a clinical audit was undertaken across four district health boards with six hospitals 
participating. 
The question to be answered in this study is: ‘What is the current practice of PN management 
throughout the Auckland/Northern region of NZ?’  
The primary aim was to examine whether PN practice in New Zealand fares better under the 
same scrutiny as the study conducted by NCEPOD. Secondary aims were: firstly, to determine 
if New Zealand has similar results to the NCEPOD study by benchmarking New Zealand PN 
practice against the ESPEN/AuSPEN (2009)and NICE (2006) guidelines. Secondly, to ensure the 
data collection methods used were appropriate for a New Zealand study. 
The main results presented in this chapter are from the adult population of patients that 
received PN in public hospitals throughout the Auckland/Northland region of NZ only. The 
themes examined were: indication for PN, type of PN, prescribing PN, CVC care, PN associated 
complications and the role and availability of NSTs. The results are expressed as a value of 
responses given; often many questions were not answered so rather than assume they were 
negative or positive responses they were not reported on. For example, the question “was this 
type of PN bag appropriate for the patient’s needs?” elicited only 48 yes or no responses out 
of the 65 cases returned for analysis. There has been no assumption made by the author that a 
blank response meant that the advisor assessors felt the type of PN bag was appropriate for 
the patient’s needs. Therefore the values and percentages provided were represented out of 
48 in this case.  
- 51 - 
 
The data provided from the organisational questionnaires based on PN management in each 
hospital is also reported. It is presented as adult, paediatric and neonatal data. However it is a 
very limited sample so cannot be assumed to be representable of other hospitals throughout 
New Zealand. 
Analysis of Data 
Six hospitals from the Auckland and Northland regions were invited to participate in the study, 
covering a population of 1.64 million. Patients of all ages were included in the study; however 
home PN patients were excluded even if they had a period of hospitalisation during the study 
period. Six hundred and twenty cases (288 adults, 68 paediatric & 264 neonates) of PN use 
were identified within the study period of Jan 1st – June 31st 2011.  A quarter of the sample, 
151 (70 adult, 17 paediatric, 64 neonate) cases were then chosen purposively in order to 
capture a range of specialities and clinicians for review by advisor assessors. Sixty six adults 
(94%), 7 paediatric (41%), 49 neonates (76%), questionnaires were returned, of these de-
Identified clinical records were available for 100% of adults and 41% of neonates for expert 
review. 
Unfortunately as discussed previously, a limitation identified during the study was the lack of 
independent local experienced paediatric and neonatal PN users to peer review the paediatric 
and neonatal PN cases. It was therefore decided to suspend review of these cases. The results 
from the paediatric and neonatal patient questionnaires which were provided by the local 
reporter are provided as Appendix 3. 
Sixty six adult cases were distributed to the advisor assessors for peer review. All 66 cases 
(patient questionnaire, clinical data and advisor assessor questionnaire) were returned to the 
primary investigator for data analysis; however one case was missing the patient questionnaire 
on its return and also one advisor assessor questionnaire was missing from a different case. 
These cases were therefore excluded from analysis. This chapter presents the results for 65 
cases in total, however not all questions were answered in all of these 65 cases, hence the 
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number of total responses does vary for each individual question. Of the cases reviewed, thirty 
three patients were male, thirty two female. 
The results of this audit are presented firstly as an overall grade assigned by the advisor 
assessors; following this, all of the descriptive data presented is from the responses given to 
each of the questions within the questionnaires. It is presented in the themes as per the 
questionnaires, indication for PN, type of PN, CVC care, PN associated complications and the 
role and availability of NSTs. In most cases the results are from the advisor assessor 
questionnaires unless otherwise stated. 
Adult Data 
Figure 4.1 outlines the age distribution of the study population. The mean age of patients that 
received PN is 61 (range 90-19). Over half of the patients receiving PN examined in this study 
were over the age of sixty (n=35) with nearly a third over the age of seventy (n=19). 
Figure 4.1 Age distribution of the study population  
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Overall Assessment of PN Care 
Only 12.7% of cases examined demonstrated ‘good practice’- the standard for which the 
advisor assessors would expect within their own practice (See table 4.1). 19% of the cases in 
this study were graded as a ‘Less than satisfactory’ standard, 65% of cases demonstrated 
aspects of care where there was ‘room for improvement’.  
Table 4.1 Overall of assessment of PN care- Advisor assessors 
Overall Assessment Number of Patients % 
Good Practice 8 12.7 
Room for Improvement 41 65.1 
Less than satisfactory 12 19 
Combined (Room for Improvement/Good Practice) 1 1.6 
Combined (Room for Improvement/Insufficient Data) 1 1.6 
Total 63  
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Examples of comments received on the grade allocated included: 
Good Practice: 
“Pre-empted risk of RFS and liaised with surgical team for additional phosphate. Patient put on 
4-6kg during admission in association with PN administered,? secondary to Na+ content in PN 
and IV antibiotics (i.e. transport fluid). Excellent assessment”. 
“Overall patient was managed well in a difficult situation”. 
Room for Improvement: 
“Peripheral PN not warranted in patient care/Little evidence of management of nutrition 
requirements/fluids/electrolytes”. 
“Poor appreciation of fluid management by NST”. 
“Some delay in recognition of need for PN”. 
“Risk of RFS not documented in assessment. Unclear as to why patient’s requirements which 
were initially based on adjusted body weight of 136kgs then reduced to 100kgs. Same nutrition 
provided but based on different weights either 18.3kgs/kg or 25kcals/kg. Patient not 
weighed??? or data missing”. 
Less than Satisfactory: 
“No indication for PN to be initiated,/No trial of oral/enteral nutrition prior to PN 
starting,/Poor documentation around CVC insertion,/assessment is working on estimated 
weight of 65kg, recorded weight of 75kgs,/There is a clear documented plan of calories being 
provided in PN but not what actual requirements are”. 
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“No dietetic involvement for entire period/no evidence of nutrition assessment/no evidence 
that Enteral Feeding considered/no past medical history”. 
Administration of PN 
Parenteral nutrition is administered in a variety of settings (See figure 4.2). The majority of 
patients requiring PN came from either general surgery 24/65 (36.9%) or critical/intensive Care 
medicine 22 (33.8%). Seven (10.8%) cases came from colorectal surgery, 5 (7.7%) from urology, 
3 (4.6%) from upper gastrointestinal surgery and 2 (3%) were from vascular surgery. Only 1 
(1.5%) case each was from nephrology and medical oncology. The complexity of patients that 
require PN is reflected in the type of ward where PN is generally administered with just over 
half being nursed in either HDU or ICU. The mean days on PN was 10.4 (range 1-109) (See 
figure 4.3) 
Figure 4.2 Ward level under which PN was administered (Patient care questionnaire 
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Figure 4.3 Number of days for which the patient received PN (Patient care questionnaire)  
 
Indication for PN  
Patients often have multiple indications for PN as a result of the complexities of their condition 
(See table 4.2). The most common reason documented indication for PN was for post -
operative Ileus.  
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Table 4.2 Documented Indications for PN. 
Documented Indication for PN Number of Patients 
Post Op Ileus 31 
Other 11 
Perforated/Leaking Gut 6 
Failure of Enteral Nutrition 5 
Post-Surgical Complications 4 
Obstruction 4 
Fistula 3 
Chemotherapy 1 
Short Bowel Syndrome 1 
Pre-Operative Nutrition 1 
Non-functioning Gut 1 
No access for enteral Nutrition 1 
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No data recorded 12 
 
More often than not, advisors agreed that PN was given for an appropriate indication 51/64 
(79.9%), however there were still examples of PN administration in situations where it was not 
considered necessary. On examination of clinical records 3 of the remaining patients that 
received PN had no clear documentation recorded as to why PN was commenced, 1 reported 
high NG losses of 250mls in a patient receiving NG feeding, perhaps suggesting intolerance to 
enteral feeding. One patient was unable to have an enteral feeding tube inserted although the 
advisor assessor was unable to find a rationale for this. 
The majority of PN was started during the weekdays, with very little being started over the 
weekend; PN is not considered to be an emergency intervention and benefits from timely 
assessment by experienced clinicians before its commencement. Thursday was the most 
common day to start PN with 16/64 cases (25%), followed by both Tuesday & Friday with 11 
cases (17.2%) each (See figure 4.3). Monday & Wednesday were the least common days of the 
week to start PN with 8 cases (12.5%) each. Ten (15.6%) patients were started on PN over 
weekends, however advisors felt that 2/10 (20%) of the patients started on PN over the 
weekend, were inappropriate (See figure 4.4).  
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Figure 4.4 Day of the week on which PN was administered, and advisor’s opinion on the 
appropriateness of PN being commenced. 
The advisor assessors found that in 11/60 cases (18.3%) there was an unreasonable delay in 
recognising that the patient required PN by the clinicians caring for them. Once the need for 
PN was identified, only in 3/61 cases (4.9%), was it thought there was an unreasonable delay in 
starting the PN (More than 24hrs). Fifty eight cases out of sixty one (95.1%) were started 
within the 24hr period after the need was identified. The advisors felt that in 51/64 (79.7%) of 
the cases reviewed PN was indicated.  
Over half of the patients 28/65 (43.1%) reviewed received no enteral feeding prior to 
commencing PN. Of the 37 that received some form of enteral feeding prior to commencing 
PN, 20 (30.8%) were receiving oral supplements with 1(1.5%) receiving both nasogastric 
feeding and oral supplementation. Nine patients (13.8%) were fed nasogastrically, 5 (7.7%) 
nasojejunally and 1 (1.5%) via a surgical jejunostomy. One patient (1.5%) was identified as 
eating and drinking prior to PN being commenced. Enteral nutrition was not adequately 
considered by the clinicians caring for the patient as an alternative means of nutrition support 
in 26.6% (17/64) of cases before PN was commenced according to the advisors. 
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Type of PN prescribed 
The types of PN available are generally either ‘standard multi-chamber off the shelf’, ‘standard 
multi-chamber with additional micronutrients’ or ‘tailored bags’. Standard PN bags are 
industry produced bags that have fixed components, these are cheaper to produce and can be 
kept in storage for long periods of time. Using standard bags with additional micronutrients 
allows the prescriber to tailor the micronutrient to the patient, however, standard bags do not 
allow any manipulation to the number of calories or the amount of fluids given.  Tailored bags 
however are able to be fully tailored to the individual’s calorie, micronutrient and fluid 
requirements as determined by the prescriber.  
The majority of patients 34/61 (55.7%) received ‘standard multi-chamber off the shelf’ PN 
initially however this was closely followed by 27 (44.3%) of patients receiving ‘tailored bags’. 
Only 6/34 (17.6%) of patients that received ‘standard of the shelf’ PN initially went on to have 
their formulas changed to ‘tailored bags’ specific for their individual requirements.  Advisors 
did not feel that the first PN bag was appropriate for the patients’ needs in 17/48 (35.4%) of 
the cases reviewed. 
Prescribing of PN 
Patients received adequate biochemical and nutritional assessment prior to commencing PN in 
31/64 cases (48.4%) according to the advisor assessors. However 20 (31.2%) patients given PN 
were considered to have not been adequately assessed. 
Clinicians completing the patient care questionnaire were asked to identify from a list of 
parameters what elements were included in their assessment of the patient prior to 
commencing PN. These were: clinical grounds (for PN), biochemical review, weight, mid-arm 
circumference, tricep circumference/skin fold thickness, grip strength and ‘other’. The 
clinicians completing the questionnaires reported that 51/63 (81%) of patients assessments 
included clinical grounds, biochemical review and weight. Four (6.3%) assessments included 
just clinical grounds and biochemical review.  In four (6.3%) cases only clinical grounds for PN 
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was assessed, two (3.2%) had clinical grounds, biochemical review, weight and grip strength 
assessed, with one (1.6%) patient having clinical grounds, biochemical review, weight and 
vascular access included in their assessment. Finally, one (1.6%) had just their weight and 
biochemical review on assessment. 
Advisors were then asked to identify from a list of parameters the elements of assessment that 
were documented. The parameters in the advisor questionnaire were clinical assessment, 
biochemical review, weight, mid arm circumference, tricep circumference/skin fold thickness, 
grip strength, pre-albumin and ‘other’.  Only 29/62 (46.8%) of patients had documented 
evidence that their assessment included clinical assessment, biochemical review and weight. 
Two (3.2%) clinical assessment, biochemical review, weight, pre-albumin and BMI (body mass 
index), two (3.2%) clinical assessment, biochemical review, weight, and BMI, four (6.4%) 
clinical assessment, biochemical review, weight and pre-albumin, one (1.6%) clinical 
assessment, biochemical review and pre-albumin.  Eight (12.9%) patients had documented 
evidence of just clinical assessment and weight being assessed, four (6.4%) clinical assessment 
and biochemical review, two (3.2%) a biochemical review and weight, two ( 3.2%) had just a 
clinical assessment documented and nine (14.5%) had only a biochemical review documented. 
Only six patients had a pre albumin recorded and in just 4 were a BMI recorded. Over half of 
the patients reviewed 35/64 (54.7%) did not have their nutritional requirements documented 
in their clinical notes.  
Forty seven out of sixty four (73.4%) patients receiving PN were also given additional fluids. In 
the opinion of the advisors the type of fluid given was appropriate for 30 (63.8%) of those 
cases. The volume given was thought to be appropriate in 25 (53.2%) of cases, however not in 
15 (31.9%). Of the 47 patients given additional fluid the advisors felt it was given 
inappropriately in 17 (36.2%) of cases. 
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PN Associated Complications  
The advisors felt that in the majority of cases, 43/64 cases (67.2%) the patients received 
adequate clinical and biochemical monitoring whilst receiving PN. However there were 
deficiencies in monitoring identified (See figure 4.5).  
 
Figure 4.5 Deficiencies in monitoring (answers may be multiple) 
There was evidence of metabolic complications occurring in most patients 34/64 (53.1%) while 
receiving PN (See figure 4.6). Advisors felt that in nearly half of the cases where metabolic 
complications occurred, 12/28 (42.9%) could have been avoided.  The majority of the 
metabolic complications that occurred 23/27 (85.2%) were however managed appropriately in 
the advisors opinion.  Twenty four patients (37.5%) did not develop any metabolic 
complications whilst receiving PN. The types of metabolic complications that occurred are 
displayed in figure 4.6. 
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Figure 4.6 Types of metabolic complications that occurred (answers may be multiple) 
Clinicians completing the patient questionnaires reported that 22/65 (33.8%) of the patients 
had documented evidence that they were at risk of re-feeding syndrome. However on review 
of the clinical data by the advisor assessors, documented evidence of the risk was only found 
in 8/65 (12.3%). Fifty six (86.2 %) cases had no documented evidence found by the advisors 
that the patients were or were not at risk of developing RFS. Following review of both the 
patient questionnaire and clinical data, in the opinion of the advisor assessors 24/57 (42.1%) of 
patients were at risk of RFS according the NICE RFS guidelines (NICE, 2006). Of the 8 patients 
with documented evidence that they were of risk of RFS which were found by the expert 
advisor assessors, 2 (25%) cases of RFS did actually occur (using the defining criteria provided 
by the co-investigator of this study). 
Advisors also identified a further case of RFS and two cases of probable RFS, none of which had 
documented evidence found that they were even at risk of RFS. In 2 cases where there was 
evidence that RFS occurred, the advisors felt that adequate precautions to prevent it were 
taken on initiation of PN, however in 1 case where it occurred they did not feel that adequate 
precautions had been taken. In 2 of the cases where it was felt that RFS had probably occurred, 
advisors did not feel adequate precautions were taken to prevent it. 
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Catheter Choice, Insertion and Care 
Forty one out of sixty five (63.1%) patients received their initial PN via a PICC (peripherally 
inserted central catheter), 23 (35.4%) via a non-tunnelled central line and only 1 patient (1.5%) 
via a peripheral line. Just over a third, 21/60 (35%) of patients were reported to have had their 
PN via a single lumen catheter. Thirty nine out of sixty five (65%) had multi-lumen catheters 
however exactly how many lumens was not recorded. 
The type of catheter that was inserted for PN was documented in the clinical records most of 
the time, 53/64 (82.8%). However of 21/64 (32.8%) cases reviewed, the catheter insertion site 
was not documented. Only 24/64 (37.5%) of patients had the position of the catheter tip 
documented in their clinical records. In the advisor assessors opinion the type of catheter 
inserted was appropriate in nearly all cases, 49/53 (92.4%) and the insertion site was 
appropriate in 40/64 (62.5%) of cases. 
Most of the time catheter care was assessed as being appropriate, with only 6/64 (9.4%) of 
cases demonstrating evidence of inappropriate care. There was evidence of central line 
complications in 18/64 (28.1%) of cases and in the advisors opinions these complications could 
have been avoided in 6/18 (33.3%) of the cases. Most of the time the advisors felt that the 
complications were managed appropriately when they did occur 12/18 (66.7%). 
Advisors found that most 45/64 (70.3%) patients did not develop any central line 
complications whilst receiving PN. A suspected line infection occurred in 11/64 (17.2%) of 
patients receiving PN making it the most common complication of those that occurred. 
However the questionnaires did not reveal if these suspected infections were later confirmed 
or not. Line misplacement occurred in 4 cases (6.2%). There was also 1 (1.6%) case each that 
developed a confirmed line infection, haematoma or a thrombosis. Three (4.7%) cases of 
complication recorded as ‘other’ were also reported. However no further description was 
provided. The mean length of time that the initial PN catheter remained in place was 10.3 
(range >1-39), although no data was recorded for 16/64 (25%) patients (See figure 4.7). 
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Figure 4.7 Length of time the initial PN catheter remained in place 
 
Most patients 30/64 (46.9%), that had a reason for central line removal documented had their 
line removed as their period of PN was completed. Eight (12.5%) had their line removed due to 
infection (either confirmed or suspected), 4 (6.2%) patients had their central lines renewed, 
and one case (1.6%) each of thrombosis and accidental removal were reported. One case 
(1.6%) of lines was removed for ‘other’ unspecified reasons. Nineteen out of sixty four (29.7%) 
of all patients reviewed, had no documented reason given for their line removal. Some 
patients 10/63 (15.9%), developed both metabolic and CVC complications (See Table 4.3).  
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Table 4.3 presents cases where there was evidence of both CVC and/or metabolic 
complications occurring. 
 Metabolic complications 
CVC Complications Yes No Total 
Yes 10 7 17 
No 24 16 40 
Total 34 23 57 
 
Availability and role of Nutrition Support Teams  
In well over half of the patients reviewed 40/65 (61.5%), a NST was involved in the decision to 
commence PN. The NST was also involved in determining the patient’s nutritional 
requirements in 46/64 (71.8%) of cases. 
The roles of NST’s in the hospitals examined in this study are presented in more detail in the 
following organisational data. 
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Organisational Data 
The following data were collected from the organizational questionnaires. It addressed the 
way in which nutrition support was managed within each of the participating hospitals, for 
example,  what type of wards the hospital has, how PN care is managed, availability of PN and 
the presence of a NST or not. 
Table 4.4 Designation of the person responsible for deciding the PN composition 
 Type of ward 
Designation Medical Surgical ICU Paed 
Med 
Paed 
Surg 
Paed 
ICU 
Neonatal 
ICU/SCBU 
Dr/Dietitian/Pharmacist/ 
Nutrition nurse specialist  
1 1 1 0 0 0 0 
Dr/Dietitian/Pharmacist 1 1 1 1 1 1 0 
Dr/Dietitian 0 0 1 0 0 0 1 
Dr 0 0 0 0 0 0 2 
Dietitian/Nurse 1 1 0 0 0 0 0 
Dietitian 1 1 1 0 0 0 0 
No data 0 0 0 0 0 0 1 
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Table 4.5 Designation of the person prescribing PN 
 Type of ward 
Designation Medical Surgical ICU Paed 
Med 
Paed 
Surg 
Paed 
ICU 
Neo 
natal 
ICU/SCB 
Phar/Nut N Spec/Diet 1 1 1 0 0 0 0 
Med S/Phar/Diet 0 0 0 1 1 1 0 
Med S(NST Surg Cons) 1 0 0 0 0 0 0 
Med S 1 2 2 0 0 0 3 
Diet 1 1 1 0 0 0 0 
Electronic/Medical Staff 0 0 0 0 0 0 1 
 
Of the six hospitals examined in this study, four hospitals had both surgical and medical adult 
wards, and an adult intensive care unit. Three of the hospitals had both a surgical and medical 
paediatric ward with two having a paediatric intensive care unit. Five of the participating 
hospitals had a neonatal intensive care unit or a special care baby unit (See figure 4.8).  
- 69 - 
 
Figure 4.8 Types of wards in hospital 
Three out of four hospitals that responded reported that a NST was involved in the PN care of 
adults, the NST were also involved in the prescribing of the PN.  One in four hospitals reported 
that there was no NST involved. There was no data provided from two hospitals that provided 
adult PN. Of the hospitals that provided PN to paediatrics and neonates there was no reported 
NST involvement in their care. 
No PN was prepared ‘on site’ in any of the participating hospitals that responded, all used an 
external manufacturer. Four hospitals that provided PN to adults, one hospital that provided 
PN to paediatrics and four hospitals that provided neonatal PN responded. PN turn around 
from prescription to being ready to administer generally took <6hrs in four hospitals that 
provided adult and four that provided neonatal PN. One paediatric PN provider reported a turn 
around time of >6hrs but less than 24hrs. 
Four of the hospitals that provided PN to adults responded and reported that they were able 
to order ‘bespoke’ i.e. individualised made to order PN bags. One hospital that provided 
paediatric PN was also able to order ‘bespoke’ bags. Of the four hospitals that responded and 
provide PN to neonates only two were able to order ‘bespoke’ PN, the other two were only 
able to order standard ‘off the shelf’ PN. Two of the hospitals that provide adult PN and one 
Hospital 1 2 3 4 5 6
N ICU
P ICU
P Surgical
P Medical
A ICU
A Surgical
A Medical
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hospital that provided neonatal PN reported that they were able to order  and be supplied 
‘bespoke’ PN bags seven days a week. Two adult PN providers, one paediatric and one 
noenatal provider were limited to ordering and being supplied with ‘bespoke’ PN on five days 
of the week. 
Maintenance stock of ‘off the shelf’ PN was kept on the ICU in three of the hospitals and on a 
surgical ward of another hospital that provided adult PN. Four neonatal units also kept a 
supply of ‘off the shelf’ standard solutions in their units. Only one hospital that provided ‘off 
the shelf’ maintenance stock kept a central record of who had received the PN. One neonatal 
unit from a different hospital also kept a central record of who had received the standard ‘off 
the shelf’ PN. None of the hospitals that provided paediatric PN maintained a stock on their 
wards. 
Three out of the four hospitals that provide PN to adults in this study reported having a NST, 
the remaining hospital reported there was no NST. Only one  hospital providing paediatric PN 
responded and reported it had a NST and 3/4 neonatal units that responded reported that 
there was no NST in their hospital for that patient group. 
Of the adult patients who had their PN managed by a NST 7/40 (17.5%) were overall graded as 
‘Good Practice’ by the advisor assessors, however only 1/25 (4%) that were not managed by a 
NST received a ‘Good Practice’ grade. Six out of twenty five (24%) of patients that were not 
managed by a NST received the grading ‘Less than satisfactory’ compared to 6/40 (15%) of 
those that were managed by a NST (See table 4.6).  
 
 
 
- 71 - 
 
Table 4.6 NST involvement in the decision to give PN, and overall assessment on PN care 
 (Adult data only). 
 Nutrition team involved in the decision to give PN 
 Yes No  
Overall Assessment Number of patients % Number of patients % *No Data 
Good Practice 7 17.5 1 4  
Room for Improvement 26 65 14 56 1 
Less than satisfactory 6 15 6 24  
Room for Imp/Good 
Practice 
  1 4  
Room for 
Imp/Insufficient Data 
  1 4  
*No grade given 1 2.5 2 8  
TOTAL 40  25  1 
 
Most of the hospitals that reported having a NST had both a doctor and a dietitian on their 
teams. Pharmacists were present in four of the NST’s with only three having a nutrition nurse 
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specialist. One hospital’s team included an IV nurse specialist and a surgical clinical nurse 
educator (See figure 4.9). 
 Figure 4.9 Compositions of NSTs 
In the three hospitals that provided adult PN with an NST, the NST carried out daily (5dys/wk) 
ward rounds, with a full multi-disciplinary meeting weekly.  The neonatal unit with a NST 
carried out a full multi-disciplinary ward round daily (5dys/wk.). The hospital that reported a 
paediatric NST only conducted a ward round and an MDT weekly.   
NST’s were asked to report on their function as a team.  Two out of three of the adult PN 
providers, NST reported that they reviewed only PN referrals, the third reviewed both enteral 
and PN referrals.  The paediatric NST reviewed PN referrals only. All nutrition referrals were 
seen by the neonate NST.  
Hospital 1 2 3 4 5 6
N Dietitian
N Doctor
P Pharmacist
P Dietitian
P Doctor
A Surgical Clinical nurse
educater
A IV Nurse Specialist
A Nutrition Nurse Specialist
A Pharmacist
A Dietitian
A Doctor
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Two out of the three adult NST reported that they had complete autonomy when it came to 
provision of PN, i.e. they were able to say no to PN, however one of them then went on to 
state that clinicians can start ‘standard formulas’ on any patient they wish to do so without any 
NST involvement.  The neonatal NST reported complete autonomy. The remaining adult NST 
and paediatric NST reported that they worked in an ‘advisory role only’, the lead clinician was 
able to overule a recommendation made by the NST should they wish to do so.  
Five of the participating hospitals reported having specific guidelines for initiating PN, one 
hospital that provided PN had no guidelines. Four out of five hospitals that responded had 
specific policies related to changing and handling of PN bags. 
Only two of the six participating hospitals had a dedicated CVL/PICC insertion service. Five 
hospitals had specific policies on insertion and care of CVL’s, one had no policy. All six did 
however have a policy for the management of CVL infection. 
Adult Outcome Data 
All of the patients in this study had their PN discontinued, none went on the have home PN. 
The following data describes patient outcomes, PN indication and outcome, and PN duration 
and outcomes. Fifty seven out of sixty five (87.7%) patients were successfully weaned of their 
PN as they were able to either resume eating and drinking orally, or else were able to be 
enterally fed (See table 4.7). Of the eight patients that died, 75% (6) developed 
hyponatraemia, 50% (4) had CVC complications. 
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Table 4.7 Adult patient outcomes 
Outcome Number of patients 
Weaned onto oral/enteral feeding 37 
Weaned & transferred to other unit 2 
Weaned, transferred to other unit & discharged home 9 
Weaned & discharged home 8 
Transferred to other unit & discharged home 1 
Weaned & died 1 
Died during hospital stay  7 
Total 65 
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Table 4.8 PN indication and outcome 
 Number of patients 
PN indication Alive Deceased 
Post-operative Ileus 26 2 
Perforated/leaking gut 5 1 
Failure of Enteral nutrition 3  
Post-surgical complications 2 1 
Obstruction 2 2 
Fistulae 3  
Chemotherapy  1 
Short Bowel 1  
Pre-op nutrition 1  
No access for enteral nutrition 1  
Failure of EF/Post Op Ileus 1  
Non-functioning gut/Failure of ent nut  1 
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Post Surg comp/Post op Ileus 1  
No data recorded 12  
Total 58 (88%) 8 (12%) 
 
Table 4.9 PN duration and outcome 
 Patient Outcome 
Number of days on 
PN 
Alive % Deceased % Total 
1-14 48 87.3 7 12.7 55 
15-28 8 88.9 1 11.1 9 
>28 2 100   2 
Total 58  8  66 
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Summary 
This chapter presented the findings of the clinical audit of the care provided to adult patients 
receiving PN in this phase one pilot study. The findings were presented in the themes of: 
indication for PN, type of PN, CVC care, PN associated complications and availability and role of 
NSTs.  The results aim to answer the study question, ‘What is the current practice of PN 
management throughout the Auckland/Northern region?’ 
In this study, overall care of PN was found to be of a disappointing standard (See table 4.1, p. 
48). Only 12.7% of cases examined demonstrated ‘good practice’ (the standard for which the 
advisor assessors would expect within their own practice). Nineteen per cent of the cases in 
this study were graded as a ‘Less than satisfactory ‘standard, and 65% of cases demonstrated 
aspects of care where there was ‘room for improvement’. The results demonstrate, like other 
studies conducted, that PN management varies considerably between different hospitals. 
Often it would appear that the clinical practice guidelines available are not adhered to.  
A secondary aim of this study was to determine the suitability of the NCEPOD data collection 
tools used for this phase one regional study. Having presented the results, the following 
chapter will discuss the results in the context of the literature reviewed as well as whether the 
tools used, were or were not found to be suitable for the phase two national study planned. 
Study limitations, implications for practice and recommendations for further study are made. 
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5. Discussion 
Introduction 
This study aimed to critically examine the current practice on PN care throughout the 
Auckland/Northlands region using a clinical audit process.  Secondary aims were to establish if 
New Zealand had similar findings to the NCEPOD ‘Mixed bag’ report and to ensure that the 
NCEPOD data collection tools were suitable for the New Zealand setting (Stewart, Mason,  et 
al., 2010). The themes examined in this study were: indication for PN, type of PN, prescribing 
PN, CVC care, PN associated complications and the role and availability of NSTs.  
In this chapter, a summary of the findings of the care provided to adults receiving PN are 
discussed in relation to the literature in an attempt to draw conclusions.  Results are compared 
to those found by NCEPOD, with the aim of establishing whether NZ has similar findings to 
those of the NCEPOD study. The chapter will go on to discuss the suitability of the NCEPOD 
methods for a NZ national study. Weakness and limitations of the study are presented, before 
implications for New Zealand practice and recommendations for future research are made.  
The Investigation of Parenteral Nutrition – Aotearoa   
Similarly to the NCEPOD study (2010), the overall care of PN in this study was found to be of a 
disappointing standard (See table 4.1, p. 46). Only 12.7% of cases examined demonstrated 
‘good practice’ (the standard for which the advisor assessors would expect within their own 
practice). Nineteen per cent of the cases in this study were graded as a ‘Less than satisfactory’ 
standard and 65% of cases demonstrated aspects of care where there was ‘room for 
improvement’.  
Indication for PN 
Although literature suggests that PN is often administered inappropriately (DeLegge, et al., 
2007; Maurer, et al., 1996), this study did not find that to be the case overall. In the hospitals 
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examined in this regional audit, 51/64 (79.7%) of patients that received PN were given it for an 
appropriate indication. NCEPODs study found that PN was given for an appropriate indication 
in 576/808 (71.3%) of cases (2010).  
There were still however, some cases in this study when PN was prescribed, where no clinical 
indications of a non-functioning gut were found. Oral or enteral feeding should always be the 
first choices when providing nutritional support as it is associated with fewer complications 
than PN (Bankhead, et al., 2009). Parenteral nutrition is only indicated for those patients that 
have a non-functioning gut (Phillips & Ponsky, 2011). Of interest is that three of the six patients 
given PN for an inappropriate indication according to the advisor assessors, were from a 
hospital that reported no NST; this may suggest increased inappropriate PN use when no NST 
is involved (DeLegge, et al., 2007; Harbottle, Brache, & Clarke, 2009). 
However, although it was agreed that PN was given for an appropriate indication, there was 
still significant evidence found in this study that alternative oral or enteral feeding options 
were not first considered and/or trialed in 26.6% (17/64) of cases. Whilst it was often difficult 
to find a documented rationale as to why oral or enteral feed was not considered, advisors 
examined clinical records and were able to draw a conclusion themselves in some cases. They 
found that in this study, PN was given inappropriately in some patients that appeared to have 
a functioning gut as demonstrated by the fact they were having their bowels opened and were 
not experiencing vomiting, bloating or any other indications of a non-functioning gut. Some 
patients received PN as it was anticipated that they may develop a post-operative ileus (3/17). 
Of concern is that for one patient given PN, the indication given was that they were not 
receiving sufficient volume of oral nutrition, strongly indicating a functioning gut. Clinicians 
also provided PN in patients that had had complicated surgeries, where the surgeon had 
advised gut rest to protect fragile surgical sites without any consideration as to whether 
feeding distal to the site of surgery may have been possible (3/17). For some patients 5/17, 
there was no rationale able to be found that oral or enteral feeding would not have been 
possible. The findings of this study are consistent with other studies that have demonstrated 
that PN is sometimes given inappropriately. 
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The findings of this audit are consistent with other studies that have demonstrated PN is 
sometimes given inappropriately and similar to the findings of NCEPOD (2010) where 32.7% 
(271/829) of cases did not receive adequate consideration of oral or enteral feeding before the 
commencement of PN (Harbottle, et al., 2009; Martin, et al., 2011; Maurer, et al., 1996; 
Stewart, Mason, et al., 2010). This inappropriate PN use could result in, increased costs, 
increased risk of potential complications and deny patients the benefits provided by feeding 
directly into the gut (Barendregt, et al., 2004; Reyes, 2002). 
Type of PN prescribed 
Most patients starting PN in this study were given a ‘standard multi-chamber off the shelf’ bag 
34/61 (55.7%), very similarly to those in the NCEPOD study, 523/935 (56%). Many of the 
patients in this study continued to receive this type of PN bag, for the duration of PN. These 
bags have components that are fixed, therefore no manipulations can be made in order to 
match the patient’s requirements in terms of macronutrients (calories/protein and nitrogen), 
fluids or electrolytes.  Standard bags are considered to be cost effective, however ESPEN 
guidelines recommend that PN prescriptions be tailored specifically for the individual. 
Consideration must be given to protein, energy and micronutrient (electrolyte and minerals) 
requirements, disease state, co-morbidities and fluid status.  
The data from this study suggests that more than half of the patients possibly received PN that 
did not fulfil their nutritional requirements, being either inadequate or in excess of their 
individual needs.  Over provision of nutrition significantly increases the likelihood of PN 
associated metabolic complications occurring. Re-feeding syndrome is of particular concern 
following initiation of PN. Standardised PN bags does not allow adherence to the NICE re-
feeding guidelines used in this audit, that make specific recommendations on how to initiate 
re-feeding in malnourished patients who may be at risk of RFS (Excellence., 2006). 
Twenty seven out of sixty one (44.3%) patients were reported to have received tailored PN, 
however, two actually received PN bags that had ‘standard’ macronutrients but had tailored 
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micronutrients provided, hence they may also have received inadequate or excessive 
macronutrients.  
Of concern is that according to advisors, 35.4% (17/48) of the first PN prescriptions in this 
study were inappropriate for the patient’s needs. This is over double of that found in the 
NCEPOD study, where only 15% (75/500) of prescriptions were considered inappropriate. 
Advisor assessors felt that on examination of the prescriptions provided (59/65) in this study, 
only 22 (37.3%) had fully ‘tailored’ bags. Tailored PN bags are able to be prescribed specifically 
to meet what the clinicians determine are the patient’s requirements. It cannot however, be 
assumed in all cases, tailored PN bags are in fact correctly prescribed.   
Indeed, three (17.6%) patients ‘tailored’ PN prescriptions (bags) examined in this study were 
considered to be inappropriate by the advisor assessors. One patient was prescribed in excess 
of their fluid requirements based on the advisors clinical assessment. Two patients were fed 
below their nutritional requirements, however one of these had been identified as at risk of 
RFS by the clinician caring for them and had purposively had their PN initiated with reduced 
macronutrients and additional vitamins.  Advisors assessed the patients risk of RFS using the 
NICE guidelines discussed previously. Unfortunately the data tools used did not capture what 
clinicians felt were patients re-feeding risks when they initiated PN. The other patient fed 
below their requirements was not identified as being at risk of RFS, and no other reason for 
underfeeding is given. This highlights the importance of clinicians understanding the 
complexity of PN provision and clearly documenting decision rationale (DeLegge, 2012). 
Prescribing PN 
In this Auckland/Northland regional audit, PN requirements were generally calculated by a 
team of clinicians together, with a dietitian being present in 61/65 (93.8%) cases. The teams 
calculating PN requirements were usually part of a NST, unsurprisingly considering most 
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hospitals in the region studied reported having a NST. This cannot be assumed a typical 
scenario throughout the remainder of New Zealand. Of interest is that, 4/18 (22.2%) cases 
where a NST was not involved, the nutritional requirements were calculated by a doctor in the 
HDU/ICU of one participating hospital. This hospital had a NST which reported being involved 
in calculating requirements in level 1 and some level 2 area’s (General wards & HDU) indicating 
that perhaps the NST in this hospital has less of a role in managing some level 2 &  level 3 (ICU) 
patients. However, it could be expected that HDU/ICU critically ill patients, often with complex 
co-morbidities, would be the very cases to benefit from a multi-disciplinary NST prescribing. 
The remaining 14 (77.8%) of patients had their requirements calculated by a dietitian alone, 
and all came from one hospital that reported not having a NST. 
Interestingly prescriptions of PN appear to be signed by a range of clinicians, although not 
always by the clinician or team that has determined the PN prescription. The hospital 
discussed above that has a NST but are not always involved in determining nutritional 
requirements in the HDU/ICU, reported occasions where they calculated nutritional 
requirements, however, the person signing the prescription was not a member of their NST.  
Unlike the UK where there are legal constraints on the prescribing of PN, here in New Zealand 
the Medicines Act  places no such restrictions on who can legally prescribe PN, although it is 
considered ‘good practice’ to be done by a trained medical officer ("Medicines Act," 1981). 
Only 25/65 (38.5%) of the cases examined in this study had their prescriptions signed by a 
medical officer. Of the remaining forty, 26 (65%) had their PN prescriptions written by a 
dietitian with 14 (35%) being written by a pharmacist. 
Catheter Choice, Insertion and Care 
It is recommended in the ESPEN guidelines that most patients requiring short term PN be given 
their PN via a PICC line or non-tunnelled CVC (Pittiruti, et al., 2009). Peripherally inserted 
central catheters (PICC) are thought to be associated with decreased infective complications 
(Gunst et al., 2011; Maki, et al., 2006). Interestedly only 14.7% (153/1042) of patients in the 
NCEPOD study received their PN via PICCs, compared to 63.1% (41/65) of patients in this study. 
Why this variance in practice occurs between the UK and in New Zealand is unknown, however 
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it may be influenced by  increasing evidence of specific PICC associated complications, such as 
mal-positioning and thrombosis (Jennings, Cann, & Smyth, 2011; Turcotte, Dubé, & 
Beauchamp, 2006).  
There is evidence that suggests increased risks of thrombosis and mal-positioning associated 
with PICC lines, however PICC lines are associated with lower incidence of infective 
complications. The findings of this study appear to corroborate this, mal-positioning occurred 
in 2/41 (4.9%) of patients with a PICC line vs. 0/23 of those with other CVCs, thrombosis 
occurred in 1/41 (2.4%) vs. 0/23. There were however, only 4/41 (9.7%) infections (either 
suspected or confirmed) in PICCs vs. 6/23 (26.1%) with other CVCs. 
Interestingly, despite evidence to suggest that mal-positioning occurs, and recommendations 
that the tip position of CVC should lie in the distal SVC for PN administration, this audit found 
that the position of the tip of the CVCs used was often not documented, 62.5% (40/64). It is 
therefore difficult to establish if checking the tip position of CVCs is part of the monitoring 
provided to those patients receiving PN, however the results of this audit would suggest not. 
This is of significant concern, considering checking the correct positioning of the CVC catheter 
following insertion can prevent many CVC related complications, particularly thrombophlebitis, 
thrombosis and mal-positioning.  
Parenteral nutrition may be administered via a peripheral cannula as long as a solution of low 
osmolality is used and under close surveillance, as PPN is known to increase the risk of 
thrombophlebitis (Pittiruti, et al., 2009). Peripheral PN administration appears to be more 
commonly practised in the UK, where NCEPOD found that 12.2% (127/1042) of patients 
received their PN in this way compared with only 1/65 (1.5%) in this study.  
Despite recommendations that a single lumen CVC may help to reduce the risk of infection in 
accordance to ESPEN guidelines, only 32.3% (21) of patients in this study had a single lumen 
catheter’s inserted for their PN. However, this is more than those found in NCEPODs study, 
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where only 27.4% (283/1034) were given their PN via single lumen catheters. Multi-lumen 
CVCs are associated with increased risk of infection due to the increased handling of these 
lines while administering other fluids and medications (Maki, et al., 2006).  
A limiting factor in the use of single lumen PN lines is that often patients requiring PN also 
often require significant additional intravenous therapy, for medications, blood products and 
other fluids. They also require frequent blood sampling as part of PN monitoring. Multi-lumens 
are preferred by clinicians because peripheral cannulas are notorious for lasting hours to a 
short number of days only. Furthermore, although no evidence has been found by the 
investigator of this study, neither have many clinicians questioned actually experienced this in 
their practice, but some clinicians report a theoretical risk of tangling, by having more than one 
CVC within the SVC. Due to this, the practicalities of inserting two CVC into the patient at the 
same time - a multi-lumen for intravenous therapies and a single lumen dedicated PN line is 
discouraged in practice. 
PN Associated Complications 
Like other PN studies conducted, this study also found that metabolic complications associated 
with PN occurred frequently. However, disappointingly in comparison to NCEPOD’s study, in 
which 39.3% (249/634) of patients developed metabolic complications, in this study, 53.1% 
(34/64) of patients developed metabolic complications. This is surprising, considering this 
study found that there was adequate clinical and biochemical monitoring in 67.2% (43/64) of 
the cases reviewed, compared with only 56.7% (387/683) of the NCEPOD cases. Why this may 
be the case is not fully understood however, it is likely to be as a result of, a lack of consensus 
as to what constitutes adequate biochemical review, what biochemistry should be reviewed 
on initiation of PN and what on-going review is necessary.  
Risk of RFS was found to be common in this study, although this risk was not always identified. 
Using the NICE (2006) guidelines to identify patients at risk of RFS, advisors found that nearly 
half of the patients in this study were at risk of RFS, 23/65 (35.4%). Of the twenty three 
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patients identified at risk of RFS, 4 (17.4%) went on to develop RFS, using the definition agreed 
as the standard to which RFS would be audited. Re-feeding was defined as ‘probable’ if there 
was a drop in serum phosphate combined with evidence of pathological development of 
extracellular fluid shift and as ‘possible’ if there was a fall in serum potassium, magnesium with 
development of such odema. Another one patient went on to develop RFS who had not been 
identified as being at risk of RFS by either the clinician caring for them or the advisor assessor.  
As discussed previously there is a lack of consensus as to a clinical definition of RFS in current 
literature (Fleuret, Reidlinger, Whelan, & Rio, 2008). NCEPODs (2010) study state that for the 
purpose of their study they did not define RFS as a drop in phosphate only, however, they do 
not go on to state what their other defining criteria included. Therefore it is not possible to 
draw comparisons to the incidence of RFS between the two studies. 
Of the eight deaths that occurred in this study, one was of a patient believed to have 
‘probably’ developed RFS as well as a CVC complication. The overall grade assigned to this 
patient was one of ‘room for improvement’, the rationale for the grade given was that the PN 
prescription was not signed for. This suggests that patients requiring PN often have complex 
issues with several co-morbidities and that despite overall good management of their PN, poor 
outcomes can still occur. 
Availability and role of Nutrition Support Teams  
The administration of PN should be carried out in consultation with a specialised nutrition 
support team whenever possible (Bischoff et al., 2009). Interdisciplinary nutrition support 
teams should be established in hospitals because effectiveness and efficiency in the 
implementation of PN are increased, they have been found to reduce complications, reduce 
inappropriate PN use and reduce costs. In this study, three out of four hospitals that provided 
PN to adults reported having a NST.  
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This study demonstrated that 87.5% (7/8) of cases assigned an overall grading of ‘good 
practice’ had an NST involved in their care, vs. only 12.5% (1/8) of cases when no NST was 
involved.  Disappointingly, of all the cases assigned the grade of ‘room for improvement’ 65% 
(26/40) of cases vs. 35% (14/40) had an NST present. Finally, there was no difference in those 
graded ‘less than satisfactory’ whether a NST was present or not, 50% (6/12) vs. 50% (6/12). 
These findings suggest that good care is more likely with a NST being present, however even 
with a NST there are still aspects of practice that are less than satisfactory or leave room for 
improvement.  A limitation of these findings is, however, the grading system used which will 
be discussed later in the chapter.  
Metabolic and CVC complications are known to occur with PN. Having a NST is believed to 
reduce the risk of complication occurring, however this study found that the incidence of such 
complications occurring remained high. One site with an NST demonstrated both metabolic 
and CVC complications occurring in 11/26 (42.3%) of cases, of these 4/11 (36.4%) had their 
complications managed appropriately. A second site reported 3/15 (20%) of cases where both 
metabolic and CVC complications occurred despite the presence of an NST, of these 33.3% 
(1/3) had their complications managed appropriately. A third site with an NST demonstrated 
only 1/26 (3.8%) case of both metabolic and CVC complications occurring which was then 
managed appropriately. The fourth site examined without an NST demonstrated both 
metabolic and CVC complications in 3/15 (20%) of cases, none of which were deemed to have 
been managed appropriately.  
The incidence of metabolic and CVC complications occurring is in keeping with the known risks 
associated with PN.  Whilst on appearance the findings discussed above may indicate that 
complications are prevalent whether or not a NST is present or not, this may not actually be 
the case. One advisor assessor discussed his findings when completing the questionnaires, “If it 
wasn’t for the fact that the NST documented incidents of complications occurring, I wouldn’t 
know. It makes it look as if more complications happen but in actual fact it is just because they 
have been identified and we know about them” It is hypothesised that the incidence of 
complications occurring when there is no NST present, may be higher than thought, however 
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they are not identified and the true incidence is therefore unknown. Of concern however, is 
the low incidence of managing complications that have occurred appropriately.  
In summary, it would appear that whilst the current practice of PN management in the 
Auckland/Northland region is overall safe, there are several significant areas of concern 
identified where remedial action is necessary in order to improve patient care. In particular is, 
overall documentation, assessment of patients to ensure appropriate use of PN, monitoring 
and managing complications appropriately when they occur.  
Validation of study tools  
A secondary aim of this study was to see if the NCEPOD data collection tools were appropriate 
for the New Zealand setting. The three questionnaires were, a patient care questionnaire 
examining clinical care given, an advisor assessors questionnaire examining and grading the 
care provided in accordance to the ESPEN/NICE guidelines and an organisational questionnaire 
examining each hospitals nutrition support practice. Before data collection was commenced, 
the project advisory group reviewed and made some amendments to the questionnaires as it 
was felt that some questions were ambiguous. Yet on analysis of the data it was still often 
difficult to ascertain and determine some of the nuances of clinical care provided. 
Validation of data tools is important when conducting audit in order to ensure results are as 
explicit and reliable as possible. For this study the tools produced by NCEPOD were used. On 
examination of the data collected in this audit, it was found that there were discrepancies in 
the way questions were asked between the patient care and advisor assessor questionnaires. 
An example of this is that when reporting the aspects of patient’s assessment. The questions 
were worded differently, and the questionnaires listed a different set of parameters, 
therefore, making it difficult to draw a parallel between what was reported to have occurred 
and what was found to have occurred. For example, in the patient care questionnaire clinicians 
were asked: Did the patient have an assessment made for the need for PN? – Y/N, followed by, 
If yes what were the elements of the assessment? The advisor assessor questionnaire asked; 
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Was there adequate nutritional and biochemical assessment of the patient prior to 
commencement of PN? – Y/N. A list of options for what was included in the assessment were 
available on both questionnaires, however, the advisor assessor questionnaire included the 
option of pre albumin, which was not included on the patient care questionnaire. 
In the case of RFS, clinicians were asked if there was documented evidence that the patient 
was at risk of RFS, however advisor assessors were asked if the patient was at risk of RFS in 
their opinion. Determining documented evidence is difficult with no real clarity of what 
documented evidence constitutes.  For example, checking serum blood results before deciding 
on a formula is essential in order to ensure the correct formula is then prescribed. However 
just because a result was available does not mean it was sighted by the PN prescriber.  If there 
was no documented evidence of a review in clinical case notes, it was considered to have not 
been done.  
How NCEPOD validate the tools they use is unknown, no evidence was found of the process 
undertaken by their group. The findings of this study suggest that the NCEPOD questionnaires 
require some adjustment in order to ensure reliability and validity before phase two of this 
study is completed. 
Adherence to guidelines 
This Auckland/Northland region audit demonstrated that using ESPEN guidelines to grade PN 
care against was not adequate for this study. Whilst the ESPEN guidelines provide 
recommendations for best feeding options for specific groups of patients, they do not actually 
provide advisors with specific practical recommendations on the management of PN.  
This audit found that there were variances in local practice that were based on experience, 
individual knowledge and the personal adoption of general practice recommendations. For 
example, one hospital in the audit added insulin directly into their PN bags for diabetic 
patients whilst none of the remainder hospitals did. There is no evidence in the ESPEN 
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guidelines as to whether this is safe to do so or not, however Austin et al. (2007) do not 
recommend the addition of components to the PN formula following compounding.  
Limitations and Weaknesses of the study  
Documentation 
Retrospective clinical audit relies on the information that is required, being available for the 
audit. This study found many instances where documentation was missing, therefore making 
some aspects of this audit impossible to complete. There were generally two reasons for 
missing clinical data, it was either never recorded in the first place or else it was not copied 
and returned with the clinical data requested by the local reporters in this study. There was a 
consensus agreement that in probability some data were missing because it had not been 
copied, provided or had ineligible dates. 
Blair et al. (2012) states that documentation is an important issue for nurses, however it is of 
paramount importance for all heath care clinicians to document the care they have provided, 
documenting the rationale and clinical thinking behind clinical decisions and interventions. As 
well as providing a factual chronological report about assessment and care of patients, it is also 
a legal requirement (NZNC, 2012). In many instances there was an implicit opinion that 
consideration/review of some aspects of practice were done however, there was no 
documented evidence of this. Of course there were also many instances of where there was 
no evidence of some aspects of practice because in fact it was not part of the clinicians care 
provided. For instance, documentation of catheter tip position was not recorded as it was 
often not reviewed as part of PN care. 
Grading 
A grading range of ‘Good practice’, Room for improvement’ and ‘Less than satisfactory’ was 
used to determine the standard of PN care in adherence to ESPEN guidelines throughout the 
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Auckland/ Northland region. Attempts to ensure consistency in overall grades assigned 
included a test case review and extensive discussion on each question asked. However, when it 
came to assigning an overall grade, a limitation of the system used was the inability to 
adequately capture a range of clinical care within each category. The grade of ‘Room for 
improvement’ was of particular concern as this grade was given for a variety of reasons 
ranging from “Some delay in recognition of need for PN” to “SIRS is mentioned by team on 
review, but no prescription of fish-oil/Poor NST/nutrition reviews-lacking details………. /No 
mention of lipids- important (see ESPEN). /No note of PICC line in brachiocephalic-No change to 
PN or mention of re-siting” 
The range in variety of reasons for the grading given is important as it was intended that this 
could provide an overview of the current standard of PN care throughout the region. On 
completion of this study, it is believed that the grading system used, was inadequate to 
accurately reflect the current standard of practice as evidenced by the example given. Whilst a 
delay in recognising the need for PN is important as delays can exacerbate and increase the 
associated malnutrition complications, the issues raised in the second part of the example are 
numerous in comparison.  
Recommendations from this study for phase two – IPNA 
On completion of this phase one study the following recommendations are made for phase 
two of the IPNA study which aims to examine PN practice nationally. 
1. In order to ensure reliability and validity of the outcomes measured in the phase two 
national study, revision of the data collection tools is essential to ensure consistency in 
the questions being asked by both the clinicians providing care as well as the advisors 
assessing care. 
2. Phase Two of IPNA – a national study examining the practice of PN care throughout all 
of NZ public hospitals. 
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3. Grading – It is recommended that the planned phase two of this study uses a grading 
system such as a Likert scale. Using a Likert scale allows the researcher to capture 
variance around a specific point. An example of what may be used is figure 5.1; 
Figure 5.1 Likert Scale 
 
       1              2              3              4              5              6             7              8              9             10 
 
 
     Less than Satisfactory                 Room for Improvement                       Good Practice 
 
Suggested further research activity 
1. NZ Standard of Practice for PN nutritional assessment – Standardised assessment 
criteria, what and how to assess patients for PN, recognising and responding to risk 
factors, on-going monitoring, and how to deal with complications appropriately. 
2. NZ Standard NST daily review. For example, ‘LIFEWRAP’ an acronym currently used by 
the WDHB NST, as a reminder of the elements to be assessed on daily review. 
(LIFEWRAP -Line, Infection, Fluid, Examination & energy, Weight, Results and Action 
Plan.) 
3. Further analysis of the literature is necessary to determine the safest CVC to be used 
for PN administration. 
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Concluding statement 
This clinical audit examined PN care throughout the Auckland/ Northland region. The themes 
of, indication for PN, type of PN, prescribing PN, CVC care, PN associated complications and 
the role and availability of NSTs were examined. Secondary aims were to establish if New 
Zealand had similar findings to the NCEPOD ‘Mixed bag’ report and to ensure the NCEPOD data 
collection tools were suitable for the New Zealand setting. 
Whilst the audit results presented are purely descriptive, with no attempt to draw any 
statistical significance, there are several trends that appear to correlate with the literature 
discussed. This study demonstrated a wide variance in local practice which is not necessarily 
evidence based or else not in accordance to ESPEN guidelines. Although in general, practice 
was deemed to be overall safe, there were still several areas of concern demonstrated in the 
standard of care provided. There is a lack of consensus as to the best way in which to care for 
patients on PN, how to initially assess patients, what to assess, what continuing monitoring is 
required and finally how best to manage any complications that may have occurred. Whilst 
there are guidelines available, they do not appear to be universally adopted. Why this might be 
the case is unknown. 
The present study has demonstrated that national guidelines on the delivery of PN care are 
essential in order to reduce inappropriate PN use, reduce complications and improve overall 
care for the complex patients requiring this particular therapy. Provision of PN care requires a 
multi-disciplinary approach with input from clinicians, dietitians, nurses and pharmacists with 
specialist knowledge of the complexities of PN administration. 
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Appendices 
Appendix 1 – Questionnaires  
 
 
 
 
  
  
PARENTERAL NUTRITION (PN) STUDY 
 
Investigation of Parenteral Nutrition- Aotearoa (IPNA) 
 
Patient Care Questionnaire CONFIDENTIAL 
 
 
IPNA Case Number: 
 
 
Name of IPNA Local Reporter:    
 
Specialty of doctor completing form:    
 
This study is examining the process of care of patients of 
all ages who received parenteral nutrition as an inpatient 
between 1st January 2011 and 30st June 2011. The 
study aims to identify areas where the care of these 
patients might have been improved (remediable factors). 
All public hospitals that admit both acute and elective 
admissions in New Zealand will be included in the study. 
 
 
 
 
Exclusions - HPN 
Information will be collected using two methods: Box cross 
and free text, where your clinical opinion will be requested. 
 
This form will be electronically scanned. Please use a 
black or blue pen. Please complete all questions with 
either block capitals or a bold cross inside the boxes 
provided e.g. 
 
Had the patient previously received PN? 
 
    Yes No 
 
If you make a mistake, please “black-out” the incorrect 
box and re-enter the correct information, e.g. 
 
Yes No 
 
 
 
If you have any queries about the study or this 
questionnaire, please contact  
Sue Larsen: 
sue.larsen@waitematadhb.govt.nz  
 
Telephone:  09 486 8920 
 
Thank you for taking the time to complete this 
questionnaire. The findings of the full study will be 
published in mid to late 2012. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FOR STUDY USE ONLY 
 
Please supply photocopies of the following case note extracts from admission to 
completion of PN.  
 
 
Inpatient annotations (i.e. the main casenotes) 
Nursing notes 
Nutrition notes (these are sometimes filed separately) 
Biochemistry results (e.g. LFT, U&Es) 
Haematology results (e.g. FBC) 
. 
Fluid balance charts (including urine output) 
 
Drug charts (including PN prescription chart) 
Nutritional charts 
Observation charts (including TPR, CVP) 
Weight chart 
Urinalysis 
 
X-ray/CT/USS reports 
 
Any operating notes 
 
 
 
Please provide a clinical summary of the patient's care in hospital 
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1. Age at time of admission years 
 
 
If less than 2 years old months weeks days 
 
 
If premature baby Gestation weeks days 
 
 
2. Gender: Male Female 
 
 
 
 
 
3. What was the date of admission? 
 
d    d m   m y   y 
 
4. What was the time of admission? 
(Please use 24-hr clock) 
 
 
 
h  h m   m 
 
 
5. a. Was the admission: A planned admission 
 
An emergency admission 
 
An Inter-hospital transfer 
 
Unknown 
 
 
b. Specialty of consultant patient admitted under 
(Please see codes on page 11) 
 
 
 
 
 
 
 
6. Under what specialty was the patient when 
the decision was made to commence PN? 
(Please see codes on page 11 ) 
 
Unknown 
 
 
7. Under what specialty was the patient when 
PN was administered? 
(Please see codes on page 11) 
 
Unknown 
 
 
8. Had the patient previously been given PN? Yes No Unknown 
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9. a. 
 
On what type of ward was 
the PN initially administered? 
Adult Medical 
Adult Surgical 
Adult Critical Care 
Paediatric Medical 
 
Paediatric Surgical 
Paediatric Critical care 
Neonatal unit (SCBU) 
Dedicated Nutrition ward/area 
Other 
 
Unknown 
 
b. What level of care 
was this ward? 
 
Level 1 Level 2 (e.g. HDU) Level 3 (e.g. ICU) 
 
Unknown 
 
 
10. a. What was the indication for PN (answers may be multiple)? 
 
Immaturity of GI function 
Congenital anomalies; gut 
Congenital anomalies; non gut 
Necrotizing enterocolitis 
Non-functioning gut 
Perforated/leaking gut 
Short bowel 
Dysphagia 
 
Obstruction 
Dysmotility 
Fistulae 
Malabsorption 
Pre-operative nutrition 
 
No access for enteral nutrition 
 
Failure of enteral nutrition 
 
Radiation enteritis 
 
GVHD 
 
Infection (e.g. C. difficile) 
Chemotherapy 
Cancer 
Volvulus 
Crohn's disease 
 
Post-surgical complications 
 
Radiation damage 
 
Post-operative ileus 
 
 
Other (please specify) 
 
 
 
 
11. a. 
Had the patient received any kind of enteral 
feeding in the week prior to the decision to 
commence PN? 
 
Yes No 
 
Unknown 
 
 
b.   If Yes, what: 
 
Oral supplements 
 
Nasogastric feeding 
 
Naso-jejunal feeding 
 
RIG 
PEG-J 
Surgical jejunostomy 
 
PEG Distal feeding 
 
c.   Why was it not possible to continue 
to feed the patient enterally? 
 
 
12. 
 
13. a. 
b. 
If PN was the first method of nutritional support, how long had 
the patient been without adequate food or nutritional support 
before the PN was started? 
 
What was the interval between the decision to start PN and its 
commencement? 
 
If greater than 1 
day, why was this? 
hrs/days            
hrs/days 
 
Unknown 
 
 
 
Unknown 
 
 
4 of 12  
14. a. 
b. 
Was a treatment goal documented? 
 
If yes what was this?   e.g. 
optimisation of nutrition pre-surgery 
 
Yes No 
 
 
 
 
 
15. a. Did the patient have an assessment made 
for the need for PN 
 
Yes No 
 
Unknown 
 
b.   If yes what were the elements of the 
assessment? 
 
Clinical grounds 
 
Biochemical review 
 
Tricep circumference/skin 
fold thickness 
Grip strength 
 
Weight Other (specify) 
 
 
 
 
16. a. 
 
 
 
Who made the decision that PN 
should be commenced (answers may 
be multiple)? 
Mid-arm circumference 
 
 
Nurse 
 
Dietitian 
 
Pharmacist 
 
Unknown 
 
 
Doctor 
specialty 
(see page 11) 
grade 
(see page 11) 
 
Other 
 
 
b. 
 
17. 
Were they members of a nutrition team? 
 
Was the decision to start the PN made in 
normal working hours (8am - 5pm, Mon - Fri)? 
Yes No 
 
 
Yes No 
Unknown 
 
 
Unknown 
 
 
 
18. 
 
 
 
 
 
 
19. 
 
What type of PN 
was first given? 
 
 
 
 
 
If this was subsequently 
changed what was it to? 
 
Multi-chamber bag (‘off the shelf') Tailored bag 
 
Multi-chamber bag with micronutrients only Unknown 
 
Multi-chamber bag with micronutrients                   Other             
 and tailored additions                                             (specify) 
Multi-chamber bag (‘off the shelf') Tailored bag 
Multi-chamber bag with micronutrients only 
 
Multi-chamber bag with micronutrients and 
tailored additions 
PN not changed 
 
Other 
(specify)  
 
20. a. 
 
Who determined the nutritional 
requirements of the patient 
 
Nurse 
 
Doctor 
 
Unknown 
(answers may be multiple)? Dietitian specialty 
(see page 11) 
Pharmacist 
 
Other 
 
grade 
(see page 11) 
 
 
b. Were they part of a nutrition team? Yes No 
 
Unknown 
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21. a. 
 
Who signed the prescription? 
Nurse 
 
Pharmacist 
 
Unknown 
 
Dietitian 
 
Other 
Doctor      
 
specialty 
(see page 11) 
grade 
(see page 11) 
 
b. Were they part of a nutrition team? 
 
c.   Was this a different individual to the 
person(s) who determined the constitution? 
Yes No 
 
 
Yes No 
Unknown 
 
 
Unknown 
 
 
 
 
22. a. 
 
Who reviewed the patient with 
respect to their PN (answers may 
be multiple)? 
Nurse 
Dietitian 
Pharmacist 
Unknown 
Doctor 
 
specialty 
(see page 11) 
grade 
(see page 11) 
 
Other 
 
 
b.  Were they part of a nutrition team? Yes No Unknown 
 
 
 
23. 
 
How often was the patient reviewed 
with respect to PN? 
Daily (7 days) 
 
Daily (working week) 
 
3-5 days/week 
1-2 days/week 
 
<1 day/week 
 
Unknown 
 
 
 
24. 
 
What was reviewed (answers may 
be multiple)? 
 
Constitution of PN 
 
 
Biochemical review 
Clinical status 
Ongoing need for PN 
Weight 
Tricep circumference/skin 
fold thickness 
 
Grip strength 
Vascular access 
Other 
 
Mid-arm circumference 
 
 
 
25. How often was the PN prescription 
re-prescribed? 
Daily (7 days) 
Daily (working week) 
Weekly 
Other 
 
Not re-prescribed 
 
Unknown 
 
 
b.  How many times was the prescription 
changed during this admission? 
 
No changes 
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26. How many CVCs did this patient have for 
PN during this admission ? 
 
Unknown 
 
Please answer the following questions with respect to the first catheter  the patient received for PN 
 
 
27. 
 
What was the initial mode of PN 
delivery 
Peripheral venous 
catheter 
 
Peripherally inserted 
central catheter 
 
Umbilical vein 
Implanted (e.g. 
Portacath) 
Centrally inserted venous 
catheter 
 
Non-tunnelled 
 
Tunelled 
 
Unknown 
 
28. 
 
 
 
 
 
 
29. 
Type of catheter Multilumen 
Cuffed 
Uncuffed 
Was the catheter inserted? Solely for PN 
 
For general central venous 
Single lumen 
 
Unknown 
 
 
 
 
Unknown 
access with one lumen for PN 
 
30. Who inserted the catheter? Nurse Other 
 
Doctor 
 
specialty 
(see page 11) 
 
grade 
(see page 11) 
 
 
Unknown 
 
31. Where was the patient when the 
catheter was inserted? 
General ward 
 
Treatment room 
Operating theatre 
 
Other 
 
Critical care 
 
Radiology department Unknown 
 
 
 
32. What insertion technique was used? Open surgical Percutaneous Unknown 
 
 
33. What asepsis precautions were 
used (answers may be muliple)? 
Gown & gloves 
 
Face mask 
 
Draping 
Skin cleansing solution 
 
Iodine 
 
Chlorhexidine 0.5% 
 
Not recorded Chlorhexidine 2.0% 
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 34. Were prophylactic antibiotics given 
during insertion of the catheter? 
 
Yes No Unknown 
 
 
 
 
35. 
 
Where was the tip of the central 
catheter positioned? 
Superior vena cava 
 
Inferior vena cava 
 
Right atrium 
Other 
 
 
 
Not applicable 
 
SVC/RA junction Not documented 
 
 
 
 
36. 
 
How was the position of the 
catheter verified? 
Image intensifier at 
time of insertion 
 
Post insertion CXR 
 
ECG 
 
 
Ultrasound 
 
Unknown 
 
 
 
 
37. For how long was the initial catheter in 
place? 
days Unknown 
 
38. If removed, what was the reason for 
removal (answers may be multiple)? 
End of PN 
Line renewal 
Infection 
Malfunction 
 
Accidental 
 
Other 
 
Occlusion 
 
Thrombosis 
 
 
 
39. Who was responsible for changing 
the PN infusion bags (answers may 
be multiple)? 
General ward nurse 
 
Other 
Specifically PN trained nurse 
 
Unknown 
 
 
 
 
40. Was access to catheter handling 
limited to PN-trained individuals? 
 
Yes No 
 
Unknown 
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41. a. Did any non-metabolic 
complications occur with the first 
catheter inserted for PN? 
 
Yes No 
 
Unknown 
 
b. If Yes which of the following 
non-metabolic complications 
occurred (answers may be 
muiltiple)? 
Line misplacement 
 
Suspected line infection 
 
Confirmed line infection 
Venous thrombosis 
 
Pneumothorax 
 
Haemothorax 
 
Phlebitis TPN-oma/extravasation 
 
Accidental line removal Neurapraxia 
 
Line occlusion Other 
 
Line fracture/rupture 
 
 
 
 
42. a. Did any metabolic complications 
occur with the first PN catheter? 
 
Yes No 
 
Unknown 
 
b. If Yes which of the following 
metabolic complications occurred 
(answers may be muiltiple)? 
Re-feeding syndrome 
abnormal liver function 
Oedema 
Hypophosphatemia 
(without re-feeding syndrome) 
 
Hypomagnesaemia 
 
Hypokalaemia 
Hypernatraemia 
Hypermagnesaemia 
Hyperphosphatemia 
Hyperkalaemia 
 
 
 
Hyperglycaemia 
 
Other 
 
 
 
 
43. a. 
 
 
 
 
 
b. 
 
 
Was there documented evidence 
that the patient was at risk from 
re-feeding syndrome? 
 
 
 
If Yes what precautions were 
taken to prevent re-feeding 
syndrome? 
Hyponatremia 
 
 
Yes No 
 
 
 
 
 
IV vitamins 
 
IV phosphate infusion 
 
Reduced initial rate of feeding 
 
Other 
 
None 
 
Unknown 
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44. a. Was the patient given insulin? Yes No Unknown 
 
b. If Yes was this: (answers 
may be multiple) 
Part of critical care standard protocol 
 
Response to PN induced hyperglycaemia 
 
Diabetic patient 
 
 
Other 
 
 
45. a. 
b. 
Were IV fluids prescribed in addition to 
the PN? 
 
If Yes was this: (answers 
may be multiple) 
Yes No 
 
 
To correct deficit 
 
To correct on-going losses 
Unknown 
 
Routine maintenance fluid provision 
 
 
Other 
 
 
 
 
 
46. In total for how many days did the patient receive PN during 
this admission? 
days Unknown 
 
47. a. Was feeding: Continuous 
 
 
 
 
 
b.  If feeding was cyclical, how many 
Cyclical 
 
Unknown 
hours/day did feeding last? hours Unknown 
 
 
48. What was the eventual 
outcome for this patient? 
Weaned onto oral/enteral feeding 
 
Home parenteral nutrition 
 
Transferred to other unit 
 
Discharged home 
 
Died during hospital stay 
 
 
Other 
 
 
 
Thank you for completing this questionnaire -  the findings of the study will be published in 
mid to late 2012 
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100 = General Surgery 
101 = Urology 
103 = Breast Surgery 
104 = Colorectal Surgery 
105 = Hepatobiliary & 
Pancreatic Surgery 
106 = Upper Gastrointestinal 
Surgery 
107 = Vascular Surgery 
110 = Trauma & Orthopaedics 
120 = Ear, Nose & Throat (ENT) 
130 = Ophthamology 
 
140 = Oral Surgery 
 
145 = Maxillo-Facial Surgery 
150 = Neurosurgery 
160 = Plastic Surgery 
161 = Burns Care 
170 = Cardiothoracic Surgery
172 = Cardiac Surgery 
173 = Thoracic Surgery 
180 = Accident & Emergency 
190 = Anaesthetics 
192 = Critical/Intensive Care 
Medicine 
 
 
300 = General Medicine 
301 = Gastroenterology 
302 = Endocrinology 
303 = Clinical Haematology 
306 = Hepatology 
307 = Diabetic Medicine 
314 = Rehabilitation 
315 = Palliative Medicine 
320 = Cardiology 
340 = Respiratory Medicine 
350 = Infectious Diseases 
352 = Tropical Medicine 
360 = Genito-Urinary Medicine 
361 = Nephrology 
370 = Medical Oncology 
400 = Neurology 
410 = Rheumatology 
430 = Geriatric Medicine 
500 = Obstetrics & Gynaecology 
501 = Obstetrics 
502 = Gynaecology 
800 = Clinical Oncology 
810 = Radiology 
820 = General Pathology 
823 = Haematology 
 
 
 
 
171 = Paediatric Surgery 
211 = Paediatric Urology 
212 = Paediatric 
Transplantation Surgery 
213 = Paediatric 
Gastrointestinal Surgery 
214 = Paediatric Trauma & 
Orthopaedics 
215 = Paediatric Ear, Nose & 
Throat 
217 = Paediatric Maxillo- 
Facial Surgery 
218 = Paediatric Neurosurgery 
220 = Paediatric Burns Care 
221 = Paediatric Cardiac 
Surgery 
222 = Paediatric Thoracic 
Surgery 
242 = Paediatric Intensive Care 
251 = Paediatric Gastroenterology 
252 = Paediatric Endocrinology 
253 = Paediatric Clinical 
Haematology 
258 = Paediatric Respiratory 
Medicine 
260 = Paediatric Medical 
Oncology 
321 = Paediatric Cardiology 
420 = Paediatrics 
421 = Paediatric Neurology 
422 = Neonatology 
 
 
 
When completing the questionnaire please use the codes below for the relevant clinician grades 
 
Consultant = CONS 
 
Non Consultant Career Grade = NCCG 
Staff and Associate Specialist = SAS 
Trainee with completed certifcate of training = CCT 
Senior specialist trainee (SpR 3+ or ST3+) = ST3 
 
Junior specialist trainee (SpR 1&2 or ST 1&2) = ST2 
 
Basic grade (FY, HO's, SHO's or CT's) = FY 
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                        PARENTERAL NUTRITION STUDY 
 
Investigation of Parenteral Nutrition in Aotearoa (IPNA) 
Advisor Assessment Form (AF) 
 
Questionnaire number 
 
 
INSTRUCTIONS FOR COMPLETION 
 
Please complete all questions with either block capitals or a bold cross inside the boxes provided. If you make a mistake, 
please "black-out" the box and re-enter the correct information. Unless indicated, please mark only one box per question. 
 
 
 
A. PATIENT AND ADMISSION DETAILS 
 
 
1. Age at time of admission years 
 
 
If less than 2 years old months weeks days 
 
 
If premature baby Gestation weeks days 
 
 
2. Gender: Male Female 
 
 
3. Date of admission / / 
 
d  d m  m 
 
 
y  y  y  y   
 
Day of week (MON, TUE, etc) 
 
 
B. INDICATION FOR PN 
 
 
 
4. Time PN first administered (24hr 
clock) 
 
: 
 
h  h m  m 
 
Date / / 
 
d  d m  m 
 
 
 
y  y  y  y   
 
Not recorded Day of week (MON, TUE, etc) 
 
 
5. a. Was consideration given to using all other 
methods of enteral nutrition as an 
alternative to PN? 
 
Yes No 
 
Unknown  
 
 
5. b. 
 
 
 
 
 
 
If no please expand on your answer 
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        6. What indication for PN was documented (answers may be multiple)? 
 
 
Immaturity of GI function 
Congenital anomalies; gut 
Congenital anomalies; non gut 
Necrotizing enterocolitis 
Non-functioning gut 
Perforated/leaking gut 
Short bowel 
Dysphagia 
Obstruction 
Dysmotility 
Fistulae 
Malabsorption 
Pre-operative nutrition 
 
No access for enteral nutrition 
Failure of enteral nutrition 
Radiation enteritis 
GVHD 
 
Infection (e.g. C. difficile) 
  Chemotherapy 
 
Post-surgical complications 
 
Volvulus 
 
Crohn's disease 
 
Cancer 
 
Radiation damage 
 
Post-op ileus 
 
 
 
Other (please specify 
 
 
 
No indication documented Insufficient data 
 
 
7. Was the PN administered for an appropriate indication? Yes No 
 
Unknown  
 
 
If No please expand on 
your answer 
 
 
8. Was there an unreasonable delay in recognising that the 
patient required PN? 
Yes No 
 
Unknown 
 
 
If Yes please expand on 
your answer 
 
 
9. Was there an unreasonable delay between the 
decision the patient required PN and the 
commencement of PN? 
Yes No 
 
Unknown  
 
 
If Yes please expand on 
your answer 
 
 
10. Was the PN started at a reasonable time of day? Yes No 
 
Unknown  
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11. Was there adequate nutritional and biochemical 
assessment of the patient prior to commencement of PN? 
Yes No 
 
Unknown  
 
 
 
b. What was included? Clinical assessment 
 
Biochemical review 
Tricep circumference/skin 
fold thickness 
 
Grip strength 
Weight Pre Albumin 
 
 
 
 
 
 
 
12. 
 
 
 
 
 
 
What type of PN bag was first 
given? 
Mid-arm circumference  Other  
                                     
 
 
 
Multi-chamber bag ('Off the shelf') 
 
 
Multi-chamber bag ('Off the shelf') with additives 
e.g. vitamins or electrolytes 
 
Tailored bag 
 
 
13. Was this type of PN bag appropriate for the patient's needs? Yes No 
 
Unknown  
 
 
If No please expand on 
your answer 
 
 
 
 
14. a Were the patient's PN requirements documented in the 
case notes? (Cal/Energy/Electrolyte/Fluid/Vitamins 
etc.) 
Yes No 
 
 
14. b 
 
 
14. c 
If Yes please were these of adequate detail? 
 
 
If No to 14b, what additional information 
should have been included? 
Yes No 
 
15. Was the PN prescription documentation adequate for the 
nursing staff to commence the PN infusion? 
Yes No 
 
Unknown
 
16. a. Was a treatment goal for PN documented? Yes No 
 
 
16. b. If Yes was it appropriate for the patient's needs? Yes No 
 
 
16. c If No to 16b, please expand on your answer 
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  17. a. 
 
Was there adequate monitoring of the patient during PN? 
 
Yes No 
 
 
 
 
 
17. b. 
 
 
 
If No what were the deficiencies? 
 
 
 
Constitution of PN 
 
 
Biochemical review 
 
 
Tricep circumference/skin 
fold thickness 
 
Grip strength 
 
Glucose Vascular access 
 
Fluid balance Weight 
 
Mid-arm circumference Other 
 
Clinical status (please specify) 
 
 
18. a. Following initiation of PN did the patient have clinical 
reviews of their underlying condition? 
Yes No 
 
 
 
18. b. If Yes was the frequency of reviews adequate? Yes No 
 
 
 
18. c. 
 
 
If Yes were the number of senior reviews adequate? 
 
 
Yes No 
 
 
 
 
19. a. Was the type of central venous catheter (CVC) documented in the 
case notes? 
Yes No 
 
 
 
19. b. If Yes was this appropriate? Yes No 
 
19. c If No to 19b please expand on your answer 
 
 
 
20. a. Was the site of insertion documented in the casenotes? Yes No 
 
 
 
20. b. 
 
 
If Yes was this appropriate? 
 
 
Yes No 
 
 
20. c If No to 20b please expand on your answer 
 
 
 
21. a. Was insertion of the CVC performed by an appropriate 
healthcare professional? 
Yes No 
Unknown  
 
21. b If No please expand on your answer 
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22. a. Was position of the CVC tip documented in the casenotes? Yes No 
 
 
  22. b.
 
Was the tip in an appropriate position? 
 
Yes No 
 
23. a. Was the insertion of the CVC adequately documented in 
the case notes? 
Yes No 
 
 
 
23. b If No which details were missing 
 
 
24. a. Is there evidence of inappropriate CVC care? Yes No 
 
 
 
24. b If Yes please expand on your answer 
 
 
25. a. Is there evidence of the CVC (PN lumen) being used 
for purposes other than PN? 
Yes No 
 
 
 
25. b If Yes what other purposes was the line 
used for 
 
26. a. Did the patient develop any CVC-related complications? Yes No 
 
 
 
26. b. 
 
 
If Yes which complications? 
 
 
 
Line misplacement 
 
 
Line fracture/rupture 
 
Suspected line infection 
 
Confirmed line infection 
Venous thrombosis 
 
Pneumothorax 
 
Phlebitis Haemothorax 
 
Accidental removal 
 
Line occlusion 
 
TPN-oma/extravasation 
 
 
Neuropraxia 
 
Other 
 
 
26. c. Were any of the complications avoidable? Yes No 
 
 
 
 
26. d 
 
 
 
If Yes please expand on your answer 
Unknown NA 
 
 
 
 
26. e. 
 
Were the complications managed appropriately Yes No 
 
Unknown NA 
 
26. e If No please expand on your answer 
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27. a. Did the patient develop any metabolic complications? Yes No 
 
 
 
 
27. b. 
 
 
 
If Yes which complications? 
 
 
 
Hypophosphataemia 
(without re-feeding 
syndrome) 
 
 
 
Hyperphosphataemia 
Hypomagnesaemia Hypermagnesaemia 
 
Hypokalaemia Hyperkalaemia 
 
Hypoglycaemia 
 
Hyponatremia 
Hyperglycaemia 
 
Hypernatraemia
          
 
 
27. c. Were any of the complications avoidable? Yes No 
 
 
 
27. d. 
 
 
If Yes please expand on your answer 
Unknown NA 
 
 
 
27. e. 
 
Were the complications managed appropriately Yes No 
 
Unknown NA 
 
27. f. If No please expand on your answer 
 
 
 
 
28. a. 
 
Did the patient develop abnormal LTF's Yes No 
 
Unknown  
 
 
 
28. b. 
 
If Yes, in your opinion was this related to overfeeding? Yes No 
 
Unknown  
 
 
 
29. a. 
 
In your opinion was the patient at risk of re-feeding Yes No 
syndrome?  Unknown  
 
 
 
29. b. 
 
 
 
 
29. c. 
 
If Yes was this documented by the clinical team? 
 
 
 
 
If Yes to 29a, were adequate precautions taken to 
prevent re-feeding syndrome? 
Yes No 
 
 
Yes No 
 
 
29. d. If No please expand on your answer 
 
 
 
 
 
29. d. 
 
Did re-feeding syndrome occur? Yes No
 7 
 
30. a. 
 
Were fluids given in addition to the PN?                                                          
 
Yes No 
 
 
 
30. b. If Yes was this for an appropriate indication? Yes No 
 
 
 
 
30. c. If No to 30b please expand on your answer 
 
 
 
30. d. If fluid was given, was the type given appropriate? Yes No 
 
 NA 
 
 
30. e. If No to 30d please expand on your answer 
 
 
30. f. If fluid was given, was the volume given appropriate? Yes No 
 
 NA 
 
 
30. g. If No to 30f please expand on your answer 
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I. OVERALL CLINICAL ASSESSMENT 
 
31. Overall assessment of care for this patient (please select one category only) 
 
Good practice - a standard of care you would expect from yourself, your trainees and 
your institution 
 
Room for improvement: aspects of clinical care that could have been better 
 
Room for improvement: aspects of organisational care that could have been better 
 
Room for improvement: aspects of clinical and organisational care that could have 
been better 
 
Less than satisfactory: several aspects of clinical and/or organisational care that were 
well below a standard that you would expect from yourself, your trainees and institution 
 
Insufficient data 
 
Please provide reasons for assigning this grade: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Are there any particular issues which you feel should be 
highlighted in the final report? 
 
If yes, please specify: 
 
Yes No 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
PARENTERAL NUTRITION STUDY 
Investigation of Parenteral Nutrition – Aotearoa (IPNA) 
 
ORGANISATIONAL QUESTIONNAIRE 
 
CONFIDENTIAL 
 
 
PLEASE COMPLETE ONE ORGANISATIONAL QUESTIONNAIRE FOR EACH HOSPITAL IN YOUR DISTRICT 
HEALTH BOARD THAT ADMINISTERS PARENTERAL NUTRITION TO INPATIENTS 
 
Name of DHB: 
Name of Hospital: 
Name of IPNA Local Reporter:    
 
Position of person(s) completing the 
questionnaire : 
What is this study about? 
 
This study will examine the process of care of patients 
of all ages who received parenteral nutrition as an 
inpatient between 1st January 2011 and June 30th 
2011. The study aims to identify areas where the care 
of these patients might have been improved 
(remediable factors). All hospitals that admit both 
acute and elective admissions throughout New 
Zealand will be included in the study. 
 
 
 
Who should complete this questionnaire? 
This questionnaire should be completed by a person 
nominated who will have the knowledge to complete it 
accurately or be able to seek help to complete it 
accurately. 
 
To ensure confidentiality of the data, completed 
questionnaires must be returned directly to Sue 
Larsen, North Shore Hospital, Waitemata 
District Health Board. 
 
Please use the SAE provided. 
 How to complete this questionnaire 
Information will be collected using two methods: Box 
cross and free text, where your clinical opinion will be 
requested. 
Please use a black or blue pen. Please complete all 
questions with either block capitals or a bold cross 
inside the boxes provided e.g. 
 
Does your hospital have a nutrition team? 
 
 Yes No 
 
If you make a mistake, please “black-out” the incorrect 
box and re-enter the correct information, e.g. 
 
 Yes  No 
 
Unless indicated, please mark only one box per 
question. 
 
Questions or help 
If you have any queries about the study or this 
questionnaire, please contact Sue Larsen at: 
 
sue.larsen@waitematadhb.govt.nz  
 
Telephone 09 486 8920 
 
Thank you for taking the time to complete this 
questionnaire. The findings of the full study will be 
published in mid to late 2012. 
 
 
FOR STUDY USE ONLY
  
1. Please indicate which wards your hospital has. 
 
(i) Adult Medical 
 
(ii) Adult Surgical 
 
(iii) Adult ICU 
Yes No 
 
Yes No 
 
Yes No 
(iv) Paediatric Medical 
 
(v) Paediatric Surgical 
 
(vi) Paediatric ICU 
Yes No 
 
Yes No 
 
Yes No 
 
*If a combined medical/surgical ward please mark both 
medical and surgical 
 
(vii) Neonatal ICU/ 
Special Care Baby Unit) 
 
Yes No 
2. a. 
b. 
 
How many PN bags were prescribed in the 2010-11 financial year? 
 
How many patients received PN as an inpatient in the 2010-11 financial year? 
 
 
Please answer questions 3 - 15 with respect to ADULT PATIENTS. If your hospital does not admit adult 
patients please go to section B on page 4 
 
 
3. a. Who decides on the composition of PN (please answer this for each type of adult ward your hospital 
has, answers may be multiple)? 
(i) Adult Medical (ii) Adult Surgical (iii) Adult ICU 
 
Medical staff 
 
Dietitian 
 
Pharmacist 
 
Nutrition nurse specialist 
 
 
Other (please specify) 
 
b. Would the above person(s) 
usually belong to the nutrition team? 
 
Yes No Yes No Yes No 
 
 
4. a. Who signs the prescription for PN in your hospital (please answer this for each type of ward your 
hospital has, answers may be multiple)? 
 
(i) Adult Medical (ii) Adult Surgical (iii) Adult ICU 
 
Medical staff 
 
Pharmacist 
 
Nutrition  nurse specialist 
 
Dietitian                                                                                                                        
 
Other (please specify) 
 
Other (please specify) 
 
b.  Would the above person(s) 
usually belong to the nutrition team? 
 
 
 
Yes No Yes No Yes No 
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5. Where is PN prepared? On-site 
 
External pharmacy (another hospital) 
 
External manufacturer 
 
6. If PN is ordered during normal working hours 
how quickly can your pharmacy/manufacturer 
supply PN (turn around time)? 
< 6 hours 
 
> 6 hours but the same day 
 
Next day 
 
7. What time does PN need to be ordered to be 
received the same day? 
  
Can your pharmacy/manufacturer supply 
 
 
 
h  h m    m 
Not available same day 
8. a. tailored bags/bags with additives? Yes No 
 
 
b.   If Yes can you order these bags: 
 
7 days/week 5 days/week 
 
Other 
 
 
9. a. Is PN supplied to the ward via the 
on-site pharmacy? 
Yes No 
 
b. Is a stock of PN maintained on 
any adult ward? 
 
Yes No 
 
c. If Yes on which wards? Adult Medical Adult Surgical Adult ICU 
 
d. If Yes to 9b, is a record of patients receiving 
PN maintained centrally (e.g. with pharmacy)? 
 
Yes No 
 
 
10. Is there an auditable trail from product to 
patient? i.e. if there was a product recall 
would it be possible to trace the batch? 
Yes No 
 
 
 
 
11. a. 
 
Does your hospital have a nutrition team for 
adult patients? 
 
Yes No 
b. If Yes who is in this team? (If No please go to section B on page 4) 
Doctor (* Please see page 11 for codes) 
 
* specialty 
 
* grade 
 
Doctor 
* specialty 
 
* grade 
 
Doctor 
* specialty 
 
* grade 
Dietitian 
 
Pharmacist 
 
Nutrition  nurse 
specialist 
 
Other (please 
specify) 
 
Other (please 
specify) 
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12. a. How often does the nutrition team 
have an MDT meeting? 
 
Weekly 
 
Fortnightly 
 
Monthly 
 
Other 
 
 
 
b. How often does the nutrition team 
undertake rounds? 
 
Daily (7 days/week) 
Daily (5 days/week) 
 
 
Weekly 
 
Other 
(please specify) 
 
 
 
13. 
 
 
 
 
 
 
14. 
 
 
 
 
15. 
 
 
What is the function of the nutrition 
team? 
 
 
 
 
With respect to ordering and administering 
PN, does the nutrition team have: 
 
 
 
Is there an over arching nutrition steering 
group/forum involved in the development 
and ratification of nutritional guidelines? 
(please specify) 
 
Review only Enteral Nutrition referrals 
 
Review only Parenteral Nutrition referrals 
 
Review both Enteral and Parenteral Nutrition 
referrals 
 
Complete autonomy (i.e. can say no to PN) 
Advisory role only 
 
Yes No 
 
 
 
 
 
Please answer questions 16 -  28 with respect to PAEDIATRIC PATIENTS. If your hospital does not admit 
Paediatric patients you do not need to complete section B. Please go to section C on page 7. 
 
 
 
16. a. Who decides on the composition of PN (please answer this for each type of paediatric ward your 
hospital has, answers may be multiple)? 
 
(i) Paediatric Medical (ii) Paediatric Surgical (iii) Paediatric ICU 
 
Medical staff 
 
Dietitian 
 
Pharmacist 
 
Nutrition  nurse specialist 
 
Dietitian                                                                                                                           
 
Other (please specify) 
 
 
b. Would the above person(s) 
usually belong to the nutrition team? Yes No Yes No Yes No 
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17. a. Who signs the prescription for PN in your hospital (please answer this for each type of ward 
your hospital has, answers may be multiple)? 
 
(i) Paediatric Medical (ii) Paediatric Surgical (iii) Paediatric ICU 
 
Medical staff 
 
Pharmacist 
 
Nutrition  nurse specialist 
 
Other (please specify) 
 
Other (please specify) 
 
b.  Would the above person(s) 
usually belong to the nutrition team? 
 
 
 
Yes No Yes No Yes No 
 
 
 
 
18. Where is PN made? On-site 
 
External pharmacy (another hospital) 
 
 
 
 
19. 
 
 
If PN is ordered during normal working hours 
how quickly can your pharmacy/manufacturer 
supply PN (turn around time)?? 
External manufacturer 
 
< 6 hours 
 
> 6 hours but the same day 
 
 
 
 
20. 
 
 
 
What time does PN need to be ordered to be 
received the same day? 
Next day 
 
 
 
 
h  h m    m 
 
 
 
not available same day 
 
21. a. 
 
Can your pharmacy/manufacturer supply 
tailored bags/bags with additives? 
 
Yes No 
 
b.  If Yes can you 
order these bags: 
 
7 days/week 5 days/week 
 
Other 
 
22. a. Is PN supplied to the ward via the 
on-site pharmacy? 
Yes No 
 
b.  Is a stock of PN maintained on 
any ward? 
 
Yes No 
c.  If Yes on which wards? Paediatric Medical Paediatric ICU 
 
 
 
 
 
 
 
 
23. 
 
 
d.  If Yes to 22b, is a record of patients receiving 
PN maintained centrally (e.g. with pharmacy)? 
 
Is there an auditable trail from product to 
patient? i.e. if there was a product recall 
would it be possible to trace the batch? 
Paediatric Surgical 
 
Yes No 
 
 
 
Yes No 
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24. a. Does your hospital have a nutrition team for 
paediatric patients? 
Yes No 
 
(If No please go to section C on page 7) 
b. If Yes who is in this team? 
Doctor (* Please see page 11 for codes) 
 
* specialty 
 
* grade 
 
Doctor 
* specialty 
 
* grade 
Doctor 
* specialty 
 
 
Dietitian 
 
 
Pharmacist 
 
Nutrition  nurse 
specialist 
 
Other (please 
specify) 
 
Other (please 
specify) 
 
* grade 
 
 
25. a. How often does the nutrition team 
have an MDT meeting? 
 
Weekly 
 
Fortnightly 
 
Monthly 
 
Other 
 
 
 
b.  How often does the nutrition team 
undertake rounds? 
 
Daily (7 days/week) 
Daily (5 days/week) 
 
 
Weekly 
 
Other 
(please specify) 
 
(please specify) 
 
 
26. 
 
 
 
 
 
 
27. 
 
 
 
 
28. 
What is the function of the nutrition 
team? 
 
 
 
 
With respect to ordering and administering 
PN, does the nutrition team have: 
 
 
 
Is there an over arching nutrition steering 
group/forum involved in the development 
and ratification of nutritional guidelines? 
Review only Enteral Nutrition referrals 
 
Review only Parenteral Nutrition referrals 
 
Review both Enteral and Parenteral Nutrition 
refferals 
 
Complete autonomy (i.e. can say no to PN) 
Advisory role only 
 
Yes No 
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Please answer questions 29 - 41 with respect to NEONATAL PATIENTS. If your hospital does not admit 
Neonatal patients you do not need to complete section C. Please go to section D on page 9 
 
 
 
 
29. a. Who decides on the composition of PN on the 
neonatal ICU/Special Care Baby Unit ? 
30. a. Who signs the prescription for PN in your 
neonatal ICU/Special Care Baby Unit ? 
 
Medical staff 
 
Dietitian 
 
Pharmacist 
 
Nutrition  nurse 
specialist 
 
Other (please specify) 
 
 
Other (please specify) 
 
b.  Would the above 
person(s) usually belong 
to the nutrition team? 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Yes No 
Medical staff 
 
Pharmacist 
 
Nutrition nurse 
specialist 
 
Other (please specify) 
 
 
Other (please specify) 
 
b.  Would the above 
person(s) usually belong 
to the nutrition team? 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Yes No 
 
 
 
31. Where is PN made? On-site 
 
External pharmacy (another hospital) 
 
 
 
 
32. 
 
 
If PN is ordered during normal working hours 
how quickly can your pharmacy/manufacturer 
supply PN (turn around time)? 
External manufacturer 
 
< 6 hours 
 
> 6 hours but the same day 
 
 
 
33. 
 
 
What time does PN need to be ordered to be 
received the same day? 
Next day 
 
 
 
h  h m    m 
 
 
not available same day 
 
34. a. 
 
Can your pharmacy/manufacturer supply 
tailored bags/bags with additives? 
 
Yes No 
 
b.  If Yes can you 
order these bags: 
 
7 days/week 5 days/week 
 
Other 
 
35. a. Is PN supplied to the ward via the 
on-site pharmacy? 
Yes No 
 
b. Is a stock of PN maintained on 
the ward? 
 
c. If Yes to 35b, is a record of patients receiving 
PN maintained centrally (e.g. with pharmacy)? 
 
Yes No 
 
 
Yes No 
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36. Is there an auditable trail from product to 
patient? i.e. if there was a product recall 
would it be possible to trace the batch? 
 
Yes No 
 
 
 
 
 
 
37. a. Does your hospital have a nutrition team for 
neonatal patients? 
Yes No 
 
(If No please go to section D on page 9) 
b. If Yes who is in this team? 
Doctor (* Please see page 11 for codes) 
 
* specialty 
 
* grade 
 
Doctor 
* specialty 
 
* grade 
Doctor 
* specialty 
 
 
Dietitian 
 
Pharmacist 
 
Nutrition  nurse 
specialist 
 
Other (please 
specify) 
 
Other (please 
specify) 
 
* grade 
 
 
38. a. How often does the nutrition team 
have an MDT meeting? 
 
Weekly 
 
Fortnightly 
 
Monthly 
 
Other 
 
 
 
b. How often does the nutrition team 
undertake rounds? 
 
Daily (7days/week) 
Daily (5 days/week) 
 
 
Weekly 
 
Other 
(please specify) 
 
(please specify) 
 
 
39. What is the function of the nutrition 
team? 
Review only Enteral Nutrition referrals 
 
Review only Parenteral Nutrition referrals 
 
 
 
40. 
 
 
 
 
 
41. 
 
 
With respect to ordering and administering 
PN, does the nutrition team have: 
 
 
 
Is there an over-arching nutrition steering 
group/forum involved in the development 
and ratification of nutritional guidelines? 
Review all Nutrition referrals 
 
Complete autonomy (i.e. can say no to PN) 
Advisory role only 
 
Yes No 
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the hospital 
 
Please answer all questions (42 - 52) in section D 
42. 
 
 
43. 
 
 
44. 
45. a. 
b. 
 
46. 
Are there hospital guidelines for initiating 
PN? 
Is there a written hospital policy for the 
changing of PN bags/line handling? 
 
Are there specialist nutrition nurses within 
your hospital? 
 
Are the ward nurses given specific training in 
the care of patients who require PN? 
 
If Yes, are they based on: 
 
 
Are there dedicated areas where PN is only 
allowed to be given? 
 
Yes No 
 
 
Yes No 
 
 
Yes No 
 
 
Yes No 
 
Specific wards Distributed across 
 
 
Yes No 
 
 
47. a. Is there audit of PN practice within your 
hospital? 
b. If Yes how often is this repeated? 
Yes No 
 
 
 
48. Is there a hospital policy on insertion and 
clinical care of central venous catheters? 
Yes No 
 
49. a. Do you have a dedicated CVC/PICC insertion 
service? 
Yes No 
 
b. If Yes who runs this service? 
(answers may be multiple) 
 
Nurse based team 
 
Radiologists 
 
Anaesthetists 
 
Surgeons 
 
Nutrition team 
 
Other 
 
 
 
 
50. 
 
 
   51a 
Is there a written hospital policy for the 
management of CVC infection? 
 
If a catheter infection is suspected which 
of the following investigations are done? 
(answers may be multiple) 
 
 
CRP 
FBC 
Yes No   
 
Pour plates 
 
Tip of line sent for culture 
(quantitative culture) 
Peripheral blood cultures Automated blood culture 
 
 
 
 
 
      b.Is Catheter routinely removed on 
suspicion of line infection? 
 
 
 
52. a. Is antibiotic prophylaxis used to prevent 
line infection during line insertion? 
Central blood cultures 
 
 
Yes           No 
 
 
 
 
Yes No 
Other 
 
b. If Yes is this for: 
 
Percutaneous Open surgical Both 
 
Thank you for completing this questionnaire - the findings of the 
study will be published in mid to late 2012 
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If needed please use this page for providing additional information (please indicate the question 
number a response relates to). 
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100 = General Surgery 
101 = Urology 
103 = Breast Surgery 
104 = Colorectal Surgery 
105 = Hepatobiliary & 
Pancreatic Surgery 
106 = Upper Gastrointestinal 
Surgery 
107 = Vascular Surgery 
110 = Trauma & Orthopaedics 
120 = Ear, Nose & Throat (ENT) 
130 = Ophthamology 
 
140 = Oral Surgery 
 
145 = Maxillo-Facial Surgery 
150 = Neurosurgery 
160 = Plastic Surgery 
161 = Burns Care 
170 = Cardiothoracic Surgery 
172 = Cardiac Surgery 
173 = Thoracic Surgery 
180 = Accident & Emergency 
190 = Anaesthetics 
192 = Critical/Intensive Care 
Medicine 
 
 
300 = General Medicine 
301 = Gastroenterology 
302 = Endocrinology 
303 = Clinical Haematology 
306 = Hepatology 
307 = Diabetic Medicine 
314 = Rehabilitation 
315 = Palliative Medicine 
320 = Cardiology 
340 = Respiratory Medicine 
350 = Infectious Diseases 
352 = Tropical Medicine 
360 = Genito-Urinary Medicine 
361 = Nephrology 
370 = Medical Oncology 
400 = Neurology 
410 = Rheumatology 
430 = Geriatric Medicine 
500 = Obstetrics & Gynaecology 
501 = Obstetrics 
502 = Gynaecology 
800 = Clinical Oncology 
810 = Radiology 
820 = General Pathology 
823 = Haematology 
 
 
 
 
171 = Paediatric Surgery 
211 = Paediatric Urology 
212 = Paediatric 
Transplantation Surgery 
213 = Paediatric 
Gastrointestinal Surgery 
214 = Paediatric Trauma & 
Orthopaedics 
215 = Paediatric Ear, Nose & 
Throat 
217 = Paediatric Maxillo- 
Facial Surgery 
218 = Paediatric Neurosurgery 
220 = Paediatric Burns Care 
221 = Paediatric Cardiac 
Surgery 
222 = Paediatric Thoracic 
Surgery 
242 = Paediatric Intensive Care 
251 = Paediatric Gastroenterology 
252 = Paediatric Endocrinology 
253 = Paediatric Clinical 
Haematology 
258 = Paediatric Respiratory 
Medicine 
260 = Paediatric Medical 
Oncology 
321 = Paediatric Cardiology 
420 = Paediatrics 
421 = Paediatric Neurology 
422 = Neonatology 
 
 
 
When completing the questionnaire please use the codes below for the relevant clinician grades 
 
Consultant = CONS 
 
Non Consultant Career Grade = NCCG 
Staff and Associate Specialist = SAS 
Trainee with completed certifcate of training = CCT 
Senior specialist trainee (SpR 3+ or ST3+) = ST3 
 
Junior specialist trainee (SpR 1&2 or ST 1&2) = ST2 
 
Basic grade (FY, HO's, SHO's or CT's) = FY 
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Appendix 2 - Consent Form 
Consent Form 
Confirmation of consent to participate in this study should be obtained from the appropriate 
hospital managers. Please return in the SAE provided to the primary researcher. 
LOCAL REPORTER 
Name 
Designation 
Signature 
Date 
MANAGER’S SIGNATURES 
Name 
Designation 
Signature 
Date 
 
Name 
Designation 
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Signature 
Date 
 
Name 
Designation 
Signature 
Date 
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Appendix 3 - Pediatric/Neonatal Data  
(Clinician Questionnaires only) 
Figure 1.2.1 Age distribution of the paediatric/neonatal study population (at time of PN) 
 
Table 1.2.1 Enteral feeding prior to commencing PN 
Enteral feed Number of patients % 
Yes 22 53.7 
No 19 46.3 
Total 41  
N/A 10  
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Table 1.2.2 Assessment made prior to commencing PN 
Assessment made Number of patients 
Yes 53 
Unknown 2 
 
Table 1.2.3 Type of ward where PN was administered 
Type of ward Number of patients % 
Paediatric Critical Care 8 14.5 
Paediatric Surgical 4 7.3 
Paediatric Medical 1 1.8 
Paediatric Medical (Oncology) 2 3.6 
Neonatal unit (SCBU) 39 71 
NICU 1 1.8 
Total 55  
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Table 1.2.4 Level of ward on which PN was administered 
Level of care Number of patients % 
Level 3 38 76 
Level 2 6 12 
Level 1 6 12 
Total 50  
 
Table 1.2.5 Indication for PN (answers may be multiple) 
Indication for PN Number of patients 
Immaturity of GI function 27 
Congenital anomalies: gut, , 6 
Congenital anomalies: non gut 2 
Necrotizing enterocolitis  5 
Non-functioning gut 3 
Perforated/leaking gut 5 
Post-operative ileus 5 
Obstruction  1 
- 111 - 
 
Post-surgical complications 4 
Failure of enteral nutrition 1 
Chemotherapy 2 
Fistulae 1 
Infection  1 
 
Table 1.2.6 Designation of the person responsible for making the decision to start PN 
Designation Number of patients 
Doctor 20 
Doctor, Dietitian 2 
Doctor, Dietitian, Pharmacist 1 
Doctor, Nurse 13 
Nurse 4 
Total 40 
Unknown 15 
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Figure 1.2.2 Specialty of doctor making the decision to commence PN 
 
Table 1.2.7 Grade of doctor making the decision to commence PN 
Grade of doctor Number of patients % 
Consultant 20 74.1 
Fellow 2 7.4 
ST3 (Senior trainee) 4 14.8 
ST2 (Junior trainee) 1 3.7 
Total 27  
Unknown 5  
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Table 1.2.8 Time between decision to start PN and its commencement 
Time Number of patients % 
0-1hr 13 42 
<1-6 hours 8 25.8 
<1day 9 29 
<2day 1 3.2 
Total 31  
Unknown 22  
 
Table 1.2.9 Specialty of doctor determining the patient’s nutritional requirements 
Speciality of doctor Number of patients 
Neonatology 18 
Paediatric surgery 5 
Paediatric ICU 4 
Paediatrics 4 
Paediatric Med Oncology/Paediatric 
Gastroenterology 
1 
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Total 32  
Figure 1.2.3 Grade of doctor determining the patients’ nutritional requirements 
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Table 1.2.10 Specialty of doctor signing the prescription 
Speciality of doctor Number of patients % 
Neonatology 12 48 
Paediatric surgery 4 16 
Paediatrics 4 16 
Paediatric ICU 2 8 
Paediatric medical oncology 2 8 
Paediatric gastroenterology 1 4 
Total 25  
 
Table 1.2.11 Grade of doctor signing the prescription 
Grade of doctor Number of patients 
Consultant 3 
Fellow 1 
ST3 (Senior trainee) 3 
ST2 (Junior trainee) 1 
HO 1 
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Total 9 
Unknown 3 
 
Figure 1.2.4 Type of PN first administered 
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Figure 1.2.5 Number of days for which PN was received 
 
Table 1.2.12 Patient outcome 
Patient outcome Number of patients % 
Weaned onto oral/enteral feeding 21 38.9 
Weaned onto oral/enteral feeding, transferred to other unit 4 7.4 
Weaned onto oral/enteral feeding, Discharged home 6 11.1 
Weaned onto oral/enteral feeding, Died during hospital stay 2 3.7 
Transfer to other unit 4 7.4 
Transferred to other unit/Died during hospital stay 1 1.9 
Died during hospital stay 3 5.6 
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Discharged home 13 24 
Total 54  
 
Table 1.2.13 Evidence of metabolic complications 
Metabolic complications Number of patients % 
Yes 18 40 
No 27 60 
Total 45  
Unknown 3  
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Figure 1.2.6 Types of metabolic complication (answers may be multiple) 
 
Table 1.2.14 Evidence of additional types of fluids 
Fluids given Number of patients % 
Yes 33 63.5 
No 19 36.5 
Total 52  
Unknown 1  
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Table 1.2.15 Initial mode of PN 
PN delivery Number of  % 
Umbilical vein 21 41.2 
Peripherally inserted central catheter 13 25.5 
Centrally inserted venous catheter 10 19.6 
Peripheral venous catheter 6 11.8 
Implanted (e.g. portacath) 1 2 
Total 51  
Unknown 2  
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Table 1.2.16 Initial type of PN catheter 
Type of catheter Number of patients % 
Multi-lumen 21 55.3 
Multi-lumen  uncuffed 4 10.5 
Single Lumen  13 34.2 
Total 38  
Unknown 3  
 
Figure 1.2.7 CVC complications 
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Appendix 4 - Ethical Approval 
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